hg_15214.1

Basic information about the TSS

---

TSS ID: hg_15214.1 Species: human Chr: chr1		Start: 156751635 End: 156751653 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000357325.10 Distance: -22 GeneID: 3068 HGNC/MGI_ID: HGNC:4856 UniProt_ID: A0A384NPW1 P51858

Gene_name: heparin binding growth factor Gene_symbol: HDGF Gene_synonyms: HMG1L2 Gene_source: HGNC:4856

TATA-Box annotation

---

Distance to TSS:	31
Nearest PromoterID:	NM_004494
Entrez ID:	3068
Nearest Unigene:	Hs.743948
Nearest Refseq:	NM_004494
Nearest Ensembl:	ENSG00000143321
Gene Name:	heparin binding growth factor
Gene Alias:	HMG1L2
Gene Description:	heparin binding growth factor
Gene Type:	protein-coding
CpG%:	0.14
GC%:	0.736318
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HDGF p2@HDGF p3@HDGF p4@HDGF p5@HDGF p6@HDGF p7@HDGF p8@HDGF p9@HDGF p10@HDGF
Sample		p1@HDGF	p2@HDGF	p3@HDGF	p4@HDGF	p5@HDGF	p6@HDGF	p7@HDGF	p8@HDGF	p9@HDGF	p10@HDGF
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	138.51	7.21	2.53	3.12	2.34	4.48	0.78	1.36	0.39	1.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	150.12	7.89	4.05	2.63	3.03	4.05	0.81	1.01	0.20	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	156.06	7.52	2.70	2.70	2.89	4.44	0.58	0.77	0.19	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	144.50	6.03	2.29	1.46	3.12	3.33	0.62	1.25	0.21	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	144.20	7.65	1.80	2.92	2.25	2.70	0.67	0.45	0.22	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	147.68	5.81	3.88	2.91	1.16	2.91	0.19	1.74	0.58	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	172.35	7.41	4.58	2.83	3.70	5.45	1.53	1.74	0.87	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	136.37	5.33	2.42	2.18	1.94	4.84	0.97	1.45	0.48	1.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	148.32	10.47	4.06	1.71	3.21	2.35	0.85	1.71	0.64	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	83.47	5.22	2.32	1.16	0.58	4.06	0.00	2.32	0.58	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	83.27	3.23	2.43	0.81	2.02	3.23	0.00	0.81	0.81	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	73.59	4.07	0.81	0.81	1.22	3.66	0.00	2.85	0.41	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	139.27	5.80	5.64	3.22	4.19	0.97	0.32	0.64	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	128.85	3.91	4.06	1.20	4.96	0.90	0.60	1.50	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	121.41	5.05	3.95	1.32	5.27	2.85	0.44	1.10	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	118.96	4.78	5.28	1.51	5.53	0.50	0.75	1.51	0.50	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	126.46	4.59	3.93	0.66	2.62	1.09	1.09	1.31	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	142.57	3.80	4.22	1.69	2.95	0.84	1.27	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	135.42	3.73	3.20	1.60	2.13	0.53	0.00	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	148.18	4.96	5.57	2.56	6.92	1.20	0.75	1.20	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	142.61	4.14	4.81	1.47	5.08	0.67	0.27	1.34	0.13	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	154.33	3.63	6.04	2.24	3.11	1.38	1.21	1.04	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	110.51	4.65	4.01	1.68	3.10	1.16	0.90	1.81	0.52	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	141.96	7.52	2.67	1.46	4.61	1.94	0.97	1.46	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	171.05	3.61	4.13	1.55	6.71	1.81	0.26	1.81	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	189.27	3.48	5.70	2.22	7.28	0.95	0.63	1.58	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	170.88	5.49	2.20	1.10	7.14	1.10	0.00	1.10	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	163.85	5.66	4.01	3.06	7.07	0.71	2.83	2.12	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	139.72	5.17	6.30	1.94	3.88	0.65	0.65	1.45	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	133.73	4.71	4.89	3.08	6.51	0.90	1.99	1.27	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	141.73	5.65	6.49	1.88	5.86	1.47	0.21	1.47	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	167.05	5.08	4.10	2.54	6.84	0.98	0.59	2.15	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	153.84	5.06	6.96	1.06	3.59	1.90	1.27	1.27	0.21	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	162.96	2.80	5.94	0.66	3.46	1.48	0.82	1.81	0.16	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	156.70	6.73	2.80	2.24	5.24	2.24	1.87	2.24	0.37	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	141.03	6.90	5.94	2.87	5.94	0.77	0.96	1.72	0.38	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	157.78	6.34	7.36	2.04	7.15	1.64	1.23	2.04	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	132.18	5.84	3.83	2.42	3.43	0.81	1.81	1.41	1.01	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	154.50	7.02	6.21	2.70	4.59	2.43	1.35	2.97	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	147.88	4.56	3.60	1.20	6.48	1.44	1.68	1.68	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	140.69	6.59	4.23	2.59	3.76	2.35	0.47	1.18	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	164.99	3.66	4.83	1.46	3.81	1.02	1.17	2.34	0.44	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	164.08	5.69	4.01	3.16	4.43	1.48	2.32	1.90	0.63	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	160.84	6.64	3.67	1.40	7.34	1.40	0.52	3.15	0.70	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	157.21	6.83	5.82	1.81	6.42	2.61	2.01	2.41	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	158.20	6.51	5.35	1.16	6.51	1.86	0.93	4.19	0.47	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	153.06	6.96	3.84	1.20	6.72	1.44	0.48	0.96	0.72	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	159.46	6.56	6.56	0.89	6.86	3.58	0.60	2.68	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	182.16	9.57	6.46	1.91	7.18	1.68	0.48	1.20	0.24	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	180.16	5.86	8.09	1.01	4.04	1.62	0.81	2.02	0.40	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	202.08	4.51	4.51	1.84	4.51	1.43	0.41	2.66	1.02	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	219.48	7.78	4.67	2.45	4.67	3.78	0.22	2.45	0.89	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	181.90	27.98	13.99	0.00	13.99	0.00	0.00	55.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	129.88	4.97	2.48	1.42	5.32	1.06	0.00	1.06	0.71	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	145.81	4.97	3.65	1.33	3.65	1.99	0.66	2.65	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	147.65	3.36	4.19	1.68	0.00	3.36	2.52	5.87	1.68	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	211.71	1.38	6.43	2.76	3.21	0.00	0.00	4.13	0.92	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	189.93	6.48	4.21	1.94	3.24	0.97	0.00	2.92	0.65	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	158.02	6.10	2.57	1.93	2.57	1.93	0.00	2.57	0.32	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	267.81	3.14	6.29	1.57	3.46	2.51	0.31	3.46	1.89	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	141.72	4.23	1.41	2.12	1.41	2.12	0.00	2.82	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	136.83	3.36	2.80	1.12	2.80	0.56	0.00	2.80	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	283.43	3.98	9.55	0.80	1.59	1.59	2.39	6.37	1.59	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	293.22	3.74	5.78	1.02	3.74	0.68	1.02	5.10	1.36	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	221.60	8.77	3.90	1.95	3.90	2.60	0.00	4.87	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	186.01	6.03	2.84	2.13	3.55	1.77	0.71	3.19	1.42	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	210.13	0.00	16.16	0.00	0.00	0.00	48.49	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	315.90	7.90	7.90	0.00	0.00	0.00	7.90	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	128.70	5.36	1.46	0.98	2.93	0.98	0.49	0.98	1.95	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	133.89	6.45	2.98	1.49	2.48	0.50	0.99	0.50	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	164.19	4.22	2.81	0.47	2.35	2.35	0.00	1.88	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	194.74	4.31	3.31	1.66	2.98	2.32	0.66	2.98	0.99	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	150.65	6.50	1.55	0.31	2.78	1.24	0.00	1.86	0.93	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	117.71	7.64	3.67	0.92	3.97	0.61	0.31	0.92	0.31	0.61
Adipocyte - breast, donor1	11376-118A8	74.12	3.33	2.85	0.95	1.43	1.27	0.16	3.17	1.27	1.11
Adipocyte - breast, donor2	11327-117E4	61.60	2.25	3.05	0.64	0.80	0.16	1.28	1.12	0.80	0.48
Adipocyte - omental, donor1	11473-119C6	69.59	2.16	3.05	0.51	1.78	1.02	0.00	1.91	1.65	0.25
Adipocyte - omental, donor2	11474-119C7	30.65	1.49	1.49	0.00	1.49	0.75	0.75	2.24	2.24	0.00
Adipocyte - omental, donor3	11475-119C8	24.11	4.02	1.34	0.00	1.34	1.67	1.34	0.67	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	24.24	1.91	0.64	0.00	0.00	1.91	0.64	0.64	1.91	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	21.99	0.00	1.10	0.00	0.00	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	97.10	3.16	4.06	1.35	2.26	0.90	0.45	0.45	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	44.49	2.78	3.13	0.00	1.91	0.35	0.87	0.52	0.52	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	125.36	4.50	5.48	1.17	1.96	0.59	0.78	0.59	0.78	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	125.86	4.12	4.38	1.03	0.51	0.77	0.77	0.51	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	103.15	3.35	3.07	1.12	0.84	0.00	0.56	1.95	1.39	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	131.67	2.35	2.35	2.94	2.35	0.59	0.59	3.53	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	97.97	3.70	6.52	0.56	0.88	0.32	0.08	0.64	0.64	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	112.64	3.87	2.58	0.00	0.32	0.32	0.00	0.00	0.97	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	82.64	1.60	5.33	1.07	1.07	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	99.60	4.45	5.01	0.00	1.67	1.11	0.56	0.56	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	66.96	3.33	4.16	0.00	1.66	0.42	0.00	0.42	2.08	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	79.37	1.76	5.02	0.50	1.76	0.25	0.25	0.25	0.25	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	63.16	1.64	3.27	0.33	1.64	0.33	0.65	0.98	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	74.29	3.96	1.83	0.91	1.22	0.00	0.61	0.30	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	171.72	9.94	7.73	3.76	2.65	1.33	0.44	1.55	0.88	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	178.57	26.18	12.55	7.89	3.59	0.00	4.66	2.51	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	131.78	5.99	5.99	2.40	3.59	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	125.39	9.36	5.04	5.58	2.16	0.72	1.08	1.08	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	100.41	6.69	5.02	3.35	1.67	0.00	1.67	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	117.31	4.93	5.96	4.93	3.29	1.64	2.67	0.62	0.41	0.21
Anulus Pulposus Cell, donor1	11248-116E6	125.64	6.52	4.92	3.09	3.55	3.43	0.92	0.92	0.80	0.46
Anulus Pulposus Cell, donor2	11463-119B5	56.08	4.90	3.43	2.20	3.43	1.47	1.22	0.24	0.73	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	145.57	5.39	3.15	1.80	1.35	1.35	2.25	3.15	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	155.42	6.95	1.74	2.17	0.43	0.87	0.87	2.60	0.87	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	231.15	4.28	4.28	0.00	2.14	0.00	4.28	6.42	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	140.49	6.28	1.49	1.20	0.90	0.60	1.20	1.79	1.49	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	136.58	5.06	5.06	2.53	0.00	0.00	2.53	5.06	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	162.38	12.54	1.98	1.98	1.32	0.00	0.66	1.32	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	135.80	5.52	0.65	1.95	1.62	0.00	0.97	1.62	1.95	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	159.22	9.22	1.94	2.43	1.46	0.97	2.91	2.43	1.46	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	163.32	5.34	3.56	2.38	0.00	0.00	1.19	2.38	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	150.28	4.90	1.88	1.51	1.13	0.38	1.13	2.26	1.13	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	166.18	4.35	0.73	0.73	2.90	0.00	1.45	1.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	145.44	12.54	2.51	2.51	2.51	0.00	0.00	1.25	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	147.11	6.59	3.46	0.82	2.47	1.32	0.66	1.65	0.49	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	218.37	5.46	4.09	1.36	0.00	1.36	1.36	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	155.31	8.29	3.02	1.36	1.66	0.75	0.15	1.51	0.15	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	148.41	11.79	1.07	3.21	1.07	0.00	2.68	2.14	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	126.02	9.82	1.70	1.89	1.13	1.32	1.89	2.46	0.94	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	182.56	7.75	1.34	1.07	0.53	2.14	2.14	2.41	1.87	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	168.75	4.88	1.95	2.93	0.98	0.00	0.98	1.95	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	109.63	7.63	3.48	1.16	1.99	1.00	1.66	2.99	0.50	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	169.30	6.00	2.40	1.20	2.40	1.20	0.00	3.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	169.93	3.54	3.54	0.00	0.00	0.00	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	131.05	8.40	2.06	2.23	2.06	1.03	0.69	0.86	0.86	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	184.58	12.58	0.00	0.00	4.19	0.00	0.00	0.00	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	138.83	7.28	2.91	1.46	0.97	0.49	2.43	1.46	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	127.12	2.66	2.66	1.90	1.14	0.00	2.66	3.42	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	172.01	9.69	2.42	1.21	2.42	2.42	0.00	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	141.37	6.84	2.28	0.57	0.57	1.14	0.57	2.28	2.28	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	120.57	5.56	2.35	1.50	1.07	1.71	1.71	2.78	1.28	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	150.98	7.48	3.61	1.81	2.06	1.29	1.55	1.03	1.29	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	158.12	7.51	0.94	0.00	1.88	0.00	1.88	2.35	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	125.73	7.40	3.86	1.93	0.32	0.64	2.89	1.29	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	153.39	6.42	0.71	1.43	2.85	0.71	0.71	4.28	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	134.54	5.85	0.58	1.17	0.00	1.17	1.17	1.75	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	125.85	5.42	2.41	1.81	1.20	0.90	2.11	2.41	0.90	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	191.27	5.94	0.00	3.56	3.56	0.00	1.19	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	154.09	5.09	2.03	0.51	1.02	0.51	3.56	2.03	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	164.02	5.60	2.55	1.53	1.02	0.76	4.58	2.55	2.04	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	165.83	6.99	1.27	0.64	1.27	0.64	0.64	1.27	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	142.41	6.47	1.29	0.86	0.86	0.43	3.02	2.16	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	119.60	7.41	3.18	3.39	1.69	0.64	1.48	1.69	1.06	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	140.93	8.99	2.32	2.32	1.16	0.58	0.87	1.45	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	136.04	7.56	1.89	3.78	0.00	2.83	0.94	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	113.07	8.82	3.22	3.39	0.85	0.68	1.36	1.53	0.51	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	155.20	11.58	4.63	0.00	0.00	2.32	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	236.61	10.56	2.11	0.00	4.23	2.11	0.00	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	138.94	8.15	3.65	2.14	0.86	1.07	1.07	3.86	0.43	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	196.74	9.02	0.60	1.20	1.80	0.60	1.20	1.20	1.80	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	160.37	7.29	2.92	2.19	2.19	0.00	2.19	3.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	168.04	7.82	3.22	3.22	1.15	1.84	2.53	2.53	1.38	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	214.23	2.55	0.00	2.55	0.00	0.00	0.00	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	172.62	8.90	1.78	1.27	1.53	0.00	0.00	1.78	1.53	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	162.06	8.46	2.06	1.86	1.03	1.65	2.27	1.86	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	194.92	8.26	2.14	1.22	0.92	0.92	2.75	2.14	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	171.13	11.95	2.87	1.91	0.96	1.43	2.87	2.39	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	176.73	8.65	2.66	2.44	1.11	0.89	2.66	1.33	1.33	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	187.67	10.68	1.53	1.53	3.05	3.05	1.53	7.63	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	146.78	12.19	3.32	1.66	0.00	1.11	2.22	2.77	2.22	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	157.55	7.94	1.85	0.53	0.53	0.53	1.85	1.85	0.53	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	187.18	9.45	1.45	1.09	2.18	0.36	1.45	2.54	1.09	0.00
Astrocyte - cerebellum, donor1	11500-119F6	111.76	11.42	11.05	5.90	2.82	2.58	0.61	1.47	0.86	0.37
Astrocyte - cerebellum, donor2	11580-120F5	107.32	13.69	8.73	7.87	3.25	1.88	1.03	2.05	0.34	0.17
Astrocyte - cerebellum, donor3	11661-122F5	107.81	8.81	5.87	2.52	3.99	1.26	1.26	1.47	0.63	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	120.61	10.81	7.32	8.37	2.44	1.39	1.39	0.70	0.70	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	192.19	13.91	7.93	6.63	3.40	1.29	3.88	0.65	0.49	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	148.71	11.34	6.71	9.25	3.43	0.45	2.24	0.89	0.30	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	148.63	5.28	8.60	4.24	3.33	4.47	3.78	1.38	0.23	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	174.89	6.51	10.65	3.13	2.38	6.51	4.38	1.00	0.38	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	162.39	6.37	8.76	3.30	2.28	7.40	2.84	1.48	0.80	0.57
Basophils, donor1	12241-129G9	84.21	1.31	5.75	0.26	0.52	0.26	0.26	0.52	0.26	0.00
Basophils, donor2	12242-129H1	141.43	2.16	7.58	1.44	1.80	0.36	0.36	0.72	0.36	0.36
Basophils, donor3	12243-129H2	86.14	2.79	7.20	0.88	1.18	0.00	0.29	0.29	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	189.52	9.27	7.98	2.16	3.67	1.51	0.22	1.51	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	201.62	16.92	9.14	3.20	1.83	1.37	2.29	0.46	0.46	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	251.07	0.00	0.00	0.00	0.00	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	247.92	14.44	7.53	6.28	3.14	1.26	3.14	0.63	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	274.08	12.89	9.36	5.61	3.54	2.08	2.70	2.08	0.83	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	167.65	8.75	9.21	3.45	3.22	0.46	2.53	1.84	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	194.16	7.74	5.94	1.62	3.06	0.72	3.06	0.54	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	139.33	16.18	6.29	5.56	1.96	11.85	0.52	1.44	0.62	1.44
Burkitt's lymphoma cell line:RAJI	10476-106I8	244.78	21.19	15.37	7.22	2.79	2.79	1.16	1.16	0.47	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	353.67	12.15	8.63	3.84	1.60	0.96	0.00	0.64	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	248.21	0.00	0.00	10.34	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	107.64	1.69	7.89	1.69	0.00	0.00	0.56	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	76.84	1.67	6.50	0.56	0.00	0.00	0.74	0.37	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	82.11	2.85	3.95	0.66	0.44	0.00	1.54	0.66	0.66	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	65.95	3.96	5.09	0.85	0.57	0.00	0.57	1.13	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	61.03	2.65	9.48	0.00	0.38	0.00	0.38	0.76	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	49.64	2.30	7.56	0.99	3.29	0.00	0.33	1.64	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	79.36	1.88	4.05	0.87	0.87	0.00	1.30	1.01	1.01	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	54.31	1.21	2.41	0.30	0.91	0.00	0.91	0.91	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	79.12	1.66	4.26	0.24	0.71	0.24	1.18	1.42	0.71	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	105.80	2.85	3.01	0.33	0.84	0.00	0.50	1.34	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	59.07	3.04	2.48	0.83	0.55	0.00	0.55	0.83	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	61.98	1.98	3.22	0.00	0.25	0.00	0.00	0.74	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	49.73	1.37	2.74	0.20	0.20	0.00	0.78	1.17	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	56.09	1.07	3.03	0.00	0.18	0.00	0.53	0.36	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	60.72	0.65	6.09	0.87	1.52	0.00	0.44	0.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	65.09	1.87	2.81	0.23	0.47	0.23	0.70	0.70	0.47	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	59.67	1.58	4.75	0.00	1.06	0.00	0.53	1.06	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	90.97	1.11	6.66	0.00	0.00	0.00	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	82.26	1.64	3.72	0.15	0.45	0.00	1.04	0.59	0.74	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	54.08	1.00	3.39	0.60	0.60	0.00	0.60	0.40	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	93.90	1.04	6.04	0.42	0.83	0.00	1.46	0.21	1.25	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	84.42	1.37	2.52	0.69	0.00	0.00	1.37	0.92	0.69	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	65.83	2.26	4.07	0.45	0.00	0.23	0.23	0.45	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	63.29	2.62	1.75	0.87	0.44	0.00	1.31	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	57.56	1.34	3.50	0.27	0.54	0.00	0.27	1.34	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	60.89	1.57	3.66	0.52	0.70	0.17	1.22	1.57	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	66.07	1.26	5.05	0.00	0.42	0.00	0.42	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	98.10	2.20	3.31	0.73	0.73	0.00	1.47	0.55	0.55	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	100.04	2.11	5.99	0.35	0.70	0.00	0.35	1.06	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	135.57	4.39	7.46	0.44	0.00	0.00	1.32	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	49.35	0.87	3.14	0.17	0.52	0.17	0.52	1.22	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	55.38	2.23	4.83	0.37	0.00	0.00	0.74	0.74	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	73.07	0.65	4.31	0.00	0.43	0.00	0.86	0.86	0.65	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	100.73	2.87	2.87	0.41	1.23	0.00	0.82	0.41	1.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	83.45	1.62	4.87	0.46	0.70	0.00	0.93	0.46	0.93	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	110.89	0.70	3.25	0.23	1.62	0.00	0.93	0.46	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	83.92	3.05	3.49	0.22	0.22	0.00	0.22	1.96	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	97.48	3.70	2.77	0.69	0.69	0.00	0.69	1.15	1.39	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	60.00	2.82	5.20	0.00	0.43	0.00	0.43	0.22	0.22	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	115.86	1.40	7.16	0.93	1.56	0.16	0.47	0.93	0.78	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	92.91	1.92	5.41	0.00	0.70	0.00	0.52	0.87	0.52	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	94.98	0.89	6.69	0.89	0.67	0.00	0.22	0.45	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	62.77	2.55	3.32	0.26	0.77	0.26	0.51	0.00	1.02	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	83.65	3.51	1.54	0.00	0.22	0.22	0.00	0.66	0.66	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	80.01	3.58	2.53	1.05	0.84	0.00	0.00	0.84	0.84	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	0.00	12.19	2.03	0.00	2.03	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	33.22	2.03	4.07	0.00	0.68	2.71	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	27.96	2.07	4.14	1.04	2.07	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	42.11	1.60	5.33	1.07	1.07	1.60	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	34.31	1.07	8.04	1.07	0.00	2.14	0.54	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	29.48	1.40	8.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	25.88	3.14	3.92	0.78	0.78	2.35	0.00	1.57	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	26.37	0.00	6.59	1.32	0.00	3.95	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	21.37	1.64	7.40	0.82	0.00	0.82	0.00	0.82	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	28.29	1.45	5.08	0.00	0.00	0.00	0.00	0.00	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	23.22	1.01	1.51	0.50	0.00	0.00	0.50	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1280.05	38.39	20.20	24.65	1.62	2.02	6.46	0.00	0.40	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	1126.16	33.16	19.97	28.36	4.39	2.00	4.39	0.00	0.80	0.40
CD34+ Progenitors, donor1	11545-120B6	46.19	2.01	3.01	0.00	0.00	0.00	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	43.26	1.69	3.93	0.00	0.56	0.56	0.00	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	222.45	10.90	12.40	3.01	1.50	1.50	0.75	1.50	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	334.84	9.47	8.34	2.48	0.68	0.68	1.35	1.35	0.45	0.68
CD4+ T Cells, donor1	11225-116C1	58.20	2.86	4.28	2.14	0.71	0.36	0.00	0.36	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	67.36	1.84	10.41	2.45	0.61	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	67.71	1.83	7.32	2.13	1.22	0.61	0.00	0.00	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	88.31	6.38	7.66	2.04	0.00	0.77	0.26	1.53	0.77	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	125.77	7.41	9.66	1.57	0.90	0.00	0.22	0.90	0.45	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	103.49	4.60	9.77	1.72	0.86	0.00	0.29	0.57	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	55.94	2.37	4.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	59.70	2.81	2.81	2.81	0.00	0.00	0.70	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	65.92	3.30	6.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	113.16	5.06	5.35	1.88	0.14	0.72	0.14	1.01	1.01	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	177.43	11.86	5.93	5.93	0.85	0.68	0.85	0.68	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	131.54	7.58	5.32	4.19	0.64	0.97	1.13	0.81	0.48	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	65.90	4.48	6.28	1.79	0.45	0.45	0.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	71.28	4.19	7.69	1.05	0.35	0.00	0.70	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	88.00	1.76	6.16	0.88	0.88	0.00	0.44	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	127.76	6.32	7.59	1.69	0.00	0.42	0.84	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	142.32	10.60	7.90	4.16	0.21	0.83	0.83	0.42	0.62	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	140.67	11.03	8.35	2.67	0.67	1.00	2.00	1.34	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	53.57	4.35	6.53	2.18	0.82	0.54	0.27	0.82	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	49.84	1.07	5.36	0.54	0.00	0.00	0.54	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	37.66	1.79	3.59	3.59	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	153.35	9.27	8.34	3.34	0.56	1.11	0.37	0.56	0.74	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	160.95	8.01	6.72	3.90	0.87	1.08	0.22	1.08	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	161.19	11.77	8.83	5.67	0.42	1.26	0.84	0.42	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	62.19	1.52	3.03	1.52	0.00	0.00	0.51	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	61.52	0.87	5.20	1.73	0.87	0.00	1.30	0.00	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	55.35	1.74	5.67	1.31	0.87	0.44	0.87	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	56.42	2.47	9.40	3.96	0.00	0.49	0.00	0.00	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	45.24	4.62	6.46	0.92	0.00	1.85	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	43.27	4.19	6.98	0.00	1.40	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	42.37	3.32	10.80	0.83	0.28	0.55	0.28	1.11	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	33.37	3.68	7.12	1.23	0.25	0.49	0.74	0.49	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	44.66	3.08	6.16	0.00	0.00	0.00	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	68.04	4.30	7.52	1.43	0.00	0.72	0.36	0.36	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	60.94	2.77	6.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	58.60	3.60	4.58	0.98	0.98	0.00	0.98	0.65	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	81.47	2.25	4.88	0.75	1.50	0.38	0.38	0.00	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	71.20	4.29	6.31	3.03	1.01	0.00	1.01	0.76	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	57.35	3.90	1.84	1.15	1.15	0.69	0.69	0.46	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	66.62	5.03	0.96	0.96	2.16	0.48	0.48	1.44	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	72.78	1.64	2.19	1.37	1.64	1.37	0.27	0.82	0.27	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	57.04	2.10	3.00	0.00	1.20	0.00	0.90	1.50	0.30	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	73.91	3.84	1.44	1.68	2.88	0.24	0.72	1.92	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	61.17	3.64	2.27	1.36	2.05	0.45	0.45	1.14	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	101.04	5.65	5.00	1.96	3.26	0.65	0.87	0.65	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	96.33	5.53	3.42	1.32	1.32	1.05	0.53	1.84	0.79	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	95.68	5.16	3.05	1.88	2.35	0.47	0.47	1.41	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	96.00	4.53	3.62	2.11	3.02	0.91	0.60	1.21	1.51	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	115.33	4.36	3.78	4.36	2.91	0.29	2.03	1.16	0.00	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	81.53	5.60	2.13	2.40	1.87	0.53	1.07	1.07	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	74.42	3.50	0.88	0.00	1.75	0.44	0.00	0.88	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	92.45	6.38	1.37	1.37	1.82	0.00	0.46	2.28	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	61.91	2.98	1.49	2.98	0.00	0.00	0.00	2.98	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	61.59	3.96	1.80	1.08	1.08	0.00	0.00	1.08	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	60.71	5.18	2.30	0.58	2.01	0.58	0.86	1.15	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	62.93	3.06	1.41	1.65	1.41	0.00	0.47	0.94	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	100.46	7.92	3.17	2.85	2.54	0.63	0.32	1.58	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	104.57	6.15	3.38	2.15	1.23	0.92	0.62	1.85	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	91.69	6.73	2.89	2.89	2.89	0.64	0.96	0.64	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	77.26	3.82	3.82	0.38	1.53	0.76	0.38	1.15	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	77.64	4.73	2.36	0.79	1.18	1.18	0.39	0.79	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	93.80	5.29	0.76	1.51	1.51	0.00	0.76	1.51	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	71.46	4.82	4.82	0.80	1.61	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	79.04	5.60	3.50	0.00	1.40	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	54.09	5.01	3.01	2.00	0.00	0.00	1.00	1.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	56.66	1.83	3.66	0.00	0.00	0.00	1.83	0.00	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	142.30	8.40	1.48	3.46	0.99	0.49	0.49	1.48	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	73.66	4.21	4.31	1.47	2.63	0.53	0.21	0.53	0.42	0.53
Chondrocyte - de diff, donor1	11261-116G1	83.55	8.32	3.81	4.85	1.73	0.00	1.04	2.08	1.39	0.69
Chondrocyte - de diff, donor2	11338-117F6	75.70	4.62	3.55	1.42	1.42	1.07	0.00	2.84	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	71.57	4.44	1.59	2.05	2.16	0.57	2.16	1.71	0.68	0.68
Chondrocyte - re diff, donor2	11339-117F7	86.84	9.85	3.58	0.90	2.69	0.90	0.00	2.69	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	59.85	3.64	4.85	2.02	8.09	0.00	0.40	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	172.25	8.26	5.39	4.25	3.79	0.92	1.15	1.03	0.23	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	121.42	5.34	3.85	3.21	4.06	1.07	2.57	1.07	0.00	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	109.21	7.35	4.78	3.89	3.98	1.24	1.15	1.42	0.35	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	88.67	3.67	5.23	1.38	4.59	1.74	0.64	0.64	0.64	0.46
Corneal Epithelial Cells, donor1	11526-119I5	236.92	14.93	11.20	6.15	2.85	0.44	0.66	0.22	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	240.03	12.51	4.55	2.28	1.14	1.14	1.14	2.28	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	263.56	10.74	7.16	6.14	4.60	0.26	4.60	1.02	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	45.90	1.65	3.30	0.50	0.66	0.17	0.17	0.99	0.99	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	34.06	1.58	3.15	1.26	0.95	0.00	0.00	1.26	0.63	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	44.86	0.00	3.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	50.32	2.16	3.13	0.86	1.73	0.32	0.76	1.40	0.86	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	123.67	3.42	11.62	1.37	2.39	0.34	0.00	1.02	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	90.75	3.26	8.49	1.96	3.92	0.00	0.00	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	67.75	3.39	11.61	0.97	2.42	0.00	0.48	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	188.12	8.17	3.84	5.84	3.00	0.00	0.50	4.50	1.33	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	134.37	4.69	1.17	5.87	1.17	0.00	0.00	2.93	1.17	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	209.55	9.62	4.52	3.11	2.83	0.57	0.57	4.52	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	160.03	9.04	0.79	3.54	2.36	0.00	1.57	4.33	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	137.29	4.65	2.91	2.62	1.16	0.29	2.91	4.36	1.75	0.87
Endothelial Cells - Artery, donor2	11341-117F9	207.52	9.41	4.47	5.18	2.12	0.00	3.06	2.82	0.71	0.71
Endothelial Cells - Artery, donor3	11413-118E9	198.10	11.75	5.79	4.38	2.45	0.70	1.23	3.51	0.88	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	86.00	5.98	1.33	1.55	1.77	0.44	0.00	3.55	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	90.37	4.56	2.13	1.83	0.30	0.30	0.61	1.22	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	69.35	5.92	1.69	0.85	0.85	0.28	0.28	2.54	0.85	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	90.33	5.35	3.86	4.16	0.59	0.00	0.59	1.78	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	104.65	3.64	3.64	1.04	0.00	0.00	0.00	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	92.59	5.10	2.27	1.56	0.99	0.28	1.42	2.41	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	128.84	6.80	5.60	2.40	0.80	0.80	0.00	6.00	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	154.09	6.29	1.05	1.05	1.57	1.57	1.57	2.10	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	208.11	11.18	4.47	3.85	0.87	0.37	0.75	3.11	0.75	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	159.25	12.82	3.69	2.82	1.30	0.22	0.43	2.17	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	176.11	13.07	5.13	5.37	1.95	0.61	0.98	2.81	0.49	0.00
Endothelial Cells - Vein, donor1	11267-116G7	164.94	5.69	6.83	10.24	2.28	1.14	1.14	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	174.63	11.18	1.40	2.79	0.00	0.00	0.00	6.29	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	175.38	11.30	4.71	5.02	2.04	0.31	2.67	2.98	0.00	0.31
Eosinophils, donor1	12244-129H3	121.98	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	145.22	1.65	11.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	146.24	0.00	10.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	196.93	13.93	8.80	2.44	2.93	2.44	0.24	1.22	0.98	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	116.49	4.16	6.24	2.08	6.24	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	113.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	93.60	6.98	2.05	1.64	6.16	1.64	0.41	1.64	0.82	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	61.53	3.61	1.09	1.31	1.31	0.88	0.44	1.64	0.44	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	152.86	8.67	2.60	4.77	3.79	0.65	1.08	2.17	0.43	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	132.44	6.43	3.03	2.91	2.30	1.46	1.33	1.94	0.12	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	42.58	2.87	2.46	1.09	1.77	1.23	0.14	1.09	0.55	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	102.20	4.64	2.53	2.11	3.38	0.74	0.74	0.74	0.53	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	38.21	2.63	1.32	0.53	0.79	1.05	1.05	1.84	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	111.62	7.64	3.32	6.64	2.66	0.33	4.32	2.33	1.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	124.29	7.71	4.08	1.81	2.72	1.81	4.08	1.81	1.36	1.36
Fibroblast - Cardiac, donor2	11345-117G4	168.26	5.31	8.34	3.03	2.27	2.27	0.76	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	95.73	5.36	3.00	2.21	2.84	0.47	1.89	1.42	0.32	0.47
Fibroblast - Cardiac, donor4	11452-119A3	74.87	5.15	4.85	2.42	0.61	0.00	0.00	0.91	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	91.37	7.49	2.79	2.41	1.27	0.13	1.78	1.27	0.13	0.51
Fibroblast - Cardiac, donor6	11460-119B2	100.20	10.16	3.03	4.24	2.27	0.45	1.52	1.36	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	69.27	6.43	4.15	2.81	1.07	0.54	0.27	0.67	0.54	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	84.99	2.59	2.16	2.16	0.86	0.43	0.43	0.43	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	108.39	11.72	4.39	2.93	0.00	1.46	1.46	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	249.78	12.92	10.38	5.54	4.15	1.15	0.23	0.92	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	123.30	8.65	2.88	1.87	1.53	0.68	0.68	1.02	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	178.20	7.75	5.17	2.82	0.70	0.94	2.58	1.17	1.17	0.23
Fibroblast - Dermal, donor2	11346-117G5	186.78	9.43	6.60	5.19	1.89	0.94	0.47	1.89	0.94	0.94
Fibroblast - Dermal, donor3	11418-118F5	187.37	11.00	3.14	4.23	3.87	0.00	2.78	0.48	0.60	0.24
Fibroblast - Dermal, donor4	11450-119A1	122.32	11.87	6.44	5.43	2.49	0.68	1.81	0.23	0.23	0.23
Fibroblast - Dermal, donor5	11454-119A5	146.72	12.91	4.71	5.58	1.92	0.35	1.22	0.70	0.17	0.17
Fibroblast - Dermal, donor6	11458-119A9	153.00	14.62	6.98	5.20	1.95	0.65	1.62	1.30	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	127.64	7.70	4.16	2.50	1.25	0.62	0.62	0.62	0.42	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	153.79	6.81	3.67	6.03	1.57	3.14	1.05	1.05	0.52	1.05
Fibroblast - Gingival, donor2	11318-117D4	168.16	13.05	4.88	5.40	1.98	2.90	2.50	0.92	0.66	0.79
Fibroblast - Gingival, donor3	11394-118C8	123.28	8.32	2.42	2.61	2.13	0.48	0.97	0.68	0.48	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	122.59	8.31	2.08	4.16	2.08	0.00	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	124.93	5.81	2.47	1.94	1.94	0.00	1.41	0.53	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	188.79	12.78	3.90	10.60	2.96	0.94	1.56	1.87	0.78	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	154.97	8.52	1.76	6.36	1.89	1.22	0.95	0.27	0.54	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	89.28	3.53	1.76	3.18	0.35	0.00	0.00	0.35	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	169.06	11.55	3.36	6.00	1.90	0.44	0.44	1.17	0.73	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	208.21	8.73	3.27	5.32	3.27	1.64	1.50	2.05	0.68	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	255.37	17.44	3.84	10.75	2.96	1.10	1.21	1.86	0.77	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	110.35	3.96	2.79	1.91	1.17	0.44	0.15	0.73	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	140.01	6.80	4.08	4.08	0.00	0.00	0.00	0.00	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	149.22	13.43	4.48	2.98	2.98	0.00	0.00	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	243.11	15.19	4.01	10.55	3.38	0.63	5.91	0.63	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	106.63	9.16	8.33	4.17	2.50	0.00	0.00	1.67	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	33.57	1.40	2.80	0.00	1.40	0.00	2.80	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	90.68	3.36	2.24	2.24	3.08	0.00	0.84	0.56	0.84	0.56
Fibroblast - Mammary, donor1	11540-120B1	192.02	8.12	5.28	5.28	2.44	0.41	0.00	1.62	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	163.76	11.98	3.99	19.97	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	77.43	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	190.48	19.79	6.01	6.98	1.75	0.78	1.16	0.97	0.58	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	218.12	14.11	6.67	8.04	1.97	1.37	1.52	0.46	0.15	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	104.04	8.87	2.75	5.81	1.22	0.31	0.00	0.92	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	95.41	8.01	1.14	6.49	1.91	1.14	1.53	1.14	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	125.01	5.13	1.35	1.89	1.08	0.27	2.43	0.81	0.27	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	123.63	6.26	3.25	2.32	1.28	0.23	1.04	0.35	0.58	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	163.92	8.51	4.31	5.64	2.32	1.44	1.88	0.77	0.55	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	138.98	9.96	5.69	5.69	3.86	1.63	0.20	1.02	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	217.17	17.37	2.00	5.35	2.67	0.00	0.67	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	150.63	7.91	3.95	3.95	3.16	0.79	2.37	0.79	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	51.40	3.97	2.78	1.98	1.19	1.39	2.38	1.59	1.39	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	90.76	4.44	3.55	1.24	0.89	0.36	0.53	1.07	0.89	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	113.52	5.91	2.37	1.77	2.56	0.79	0.59	1.58	0.79	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	43.92	4.81	3.01	2.41	0.00	0.00	0.60	1.50	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	89.17	5.94	4.21	1.84	1.51	0.65	0.43	1.51	0.43	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	32.39	2.28	2.78	1.52	0.76	0.51	1.52	0.51	1.01	0.25
Fibroblast - skin normal, donor1	11553-120C5	98.45	5.58	4.76	1.97	2.63	1.31	0.49	1.80	1.31	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	75.79	4.01	3.81	2.61	0.80	0.80	0.80	0.80	1.40	0.60
Fibroblast - skin normal, donor2	11561-120D4	82.98	4.62	4.52	1.21	1.11	1.11	0.60	2.51	0.80	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	55.91	3.93	4.53	1.81	0.60	1.51	0.91	0.60	0.91	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	171.08	7.79	4.64	1.66	2.32	0.91	0.50	1.33	1.24	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	72.48	7.18	2.39	1.20	1.88	0.51	0.68	1.54	0.34	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	33.83	2.63	1.64	0.99	0.33	2.63	0.66	1.97	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	70.84	6.28	3.83	3.41	1.28	1.07	0.96	1.81	1.81	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	170.03	11.98	4.22	8.60	1.52	0.51	0.84	1.69	1.18	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	124.83	2.98	3.92	1.25	1.88	0.94	2.51	2.04	1.25	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	332.40	22.16	0.00	0.00	0.00	0.00	44.32	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	187.38	5.23	1.74	3.49	0.87	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	202.66	8.32	5.03	1.39	0.87	1.04	0.00	1.56	0.69	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	214.96	9.37	7.81	3.12	2.34	0.52	0.26	0.52	0.78	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	189.33	7.92	5.62	3.58	1.53	0.77	0.00	1.28	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	331.48	31.39	11.48	7.66	1.53	12.25	0.77	4.59	0.77	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	332.44	18.50	6.38	4.47	1.91	10.21	3.83	5.10	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	435.31	24.82	13.69	11.70	4.56	11.98	3.42	8.56	0.57	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	407.02	21.23	15.99	11.03	5.52	1.65	1.65	1.65	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	226.50	17.58	6.39	14.38	6.16	2.05	1.37	1.37	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	348.11	23.97	11.29	10.70	3.37	9.31	0.59	5.55	0.99	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	418.44	25.11	11.63	10.04	6.34	2.91	1.06	2.38	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	214.93	26.74	7.50	15.33	5.87	1.63	0.65	1.30	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	366.16	23.88	11.50	10.17	2.65	11.94	0.88	6.63	1.33	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	122.81	11.31	7.77	3.82	1.13	8.06	3.67	1.27	0.00	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	99.50	9.24	5.05	4.56	3.32	2.22	2.09	2.09	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	130.28	8.06	5.37	2.95	0.81	5.37	3.22	1.88	0.27	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	130.83	7.93	7.31	3.10	0.99	2.23	3.84	2.11	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	126.11	9.55	6.37	2.35	2.21	2.49	3.74	1.25	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	117.51	5.90	6.10	1.83	2.44	3.86	3.46	1.22	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	135.54	7.07	5.02	1.37	2.51	1.83	1.60	0.46	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	112.48	5.98	5.98	2.87	1.25	2.37	3.61	0.87	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	118.47	8.74	5.03	3.28	0.44	3.93	1.53	1.09	0.22	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	146.85	6.50	5.61	2.66	1.48	1.48	2.36	0.59	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	122.08	11.13	6.84	3.81	2.54	1.27	4.61	0.48	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	92.50	6.93	4.92	3.80	2.23	2.01	0.89	0.67	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	156.67	10.08	4.03	3.23	4.84	2.02	1.41	0.40	0.00	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	114.85	7.63	5.43	3.39	2.71	1.36	4.41	1.53	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	134.78	10.82	4.97	3.72	2.39	2.75	0.62	0.71	0.44	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	125.39	9.99	4.99	2.91	3.43	1.35	0.42	0.42	0.10	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	124.84	7.34	4.78	2.56	3.24	1.02	0.51	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	99.37	9.85	6.75	3.87	1.99	1.22	3.10	1.33	0.11	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	116.06	8.07	4.33	3.00	2.66	2.50	0.83	0.83	0.67	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	99.03	9.19	3.88	2.25	2.45	2.65	0.41	0.00	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	130.39	9.08	3.71	2.89	3.71	1.03	2.68	0.21	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	111.37	10.61	5.42	3.57	2.88	1.73	3.23	0.46	0.12	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	110.90	9.01	3.50	2.17	3.17	1.50	2.00	1.00	0.17	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	107.79	6.83	3.97	2.20	3.31	0.00	0.88	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	98.64	7.87	6.76	2.71	3.94	0.49	2.34	0.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	98.23	8.43	5.02	2.76	2.43	0.65	1.46	1.46	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	103.27	7.70	6.74	3.21	4.17	1.60	0.32	0.32	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	72.87	6.63	5.50	2.46	3.60	0.95	2.65	0.47	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	91.74	6.17	4.90	3.32	3.01	1.11	0.32	0.79	0.00	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	89.40	4.87	3.04	2.13	1.22	1.52	2.13	1.22	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	70.98	5.12	4.39	1.88	2.72	0.73	2.40	0.84	0.10	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	81.02	6.37	4.17	2.42	3.29	0.00	0.66	0.44	0.22	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	79.11	3.65	3.93	2.24	1.68	1.40	0.84	0.56	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	70.37	5.00	3.33	1.20	1.94	1.02	1.11	0.93	0.56	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	87.17	2.94	2.67	4.01	4.28	1.07	1.07	1.60	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	84.15	6.27	3.83	3.98	1.99	0.61	1.38	1.07	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	65.42	6.48	2.98	3.11	1.42	0.78	2.20	0.65	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	65.33	5.69	2.17	1.63	1.63	0.00	0.81	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	98.44	7.01	3.87	1.84	3.13	1.11	0.92	0.37	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	80.49	6.14	2.19	2.41	1.32	0.44	2.19	0.88	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	34.71	3.97	0.00	0.00	1.98	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	108.56	5.54	2.90	2.11	2.64	0.53	1.19	0.40	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	111.77	6.05	2.82	1.21	2.82	1.21	0.20	2.02	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	34.57	1.02	1.52	0.51	3.56	0.76	0.00	0.51	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	96.54	11.35	11.35	2.99	0.80	9.36	1.39	2.19	1.00	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	114.94	11.09	7.24	3.85	2.62	3.85	2.62	0.62	0.00	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	172.87	14.93	10.43	4.09	1.02	6.34	4.09	2.05	0.00	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	332.02	28.16	7.51	6.88	3.44	9.70	0.94	4.38	0.63	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	296.68	26.28	8.76	9.61	1.70	8.76	1.41	2.54	0.28	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	177.56	16.60	6.92	6.92	1.38	5.07	1.84	1.84	0.00	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	259.85	24.75	4.95	7.42	0.00	2.47	2.47	9.90	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	328.79	13.54	5.42	6.96	2.71	13.54	3.87	1.93	0.39	2.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	258.32	12.84	0.00	3.21	4.81	4.81	4.81	1.60	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	278.21	24.34	5.22	10.43	1.74	22.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	292.61	15.62	6.51	6.51	1.63	16.92	1.30	1.95	0.33	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	269.73	21.00	8.24	4.12	0.82	10.30	2.06	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	259.92	13.33	10.00	3.33	3.33	19.99	3.33	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	244.41	13.42	8.39	6.99	0.84	14.26	2.24	1.12	0.28	2.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	260.82	18.96	7.52	4.25	0.98	14.71	1.63	1.96	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	223.13	12.58	10.07	3.36	1.68	5.87	0.84	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	243.33	18.77	9.54	3.82	1.27	7.95	1.59	1.91	0.32	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	257.46	13.25	7.81	3.74	1.36	11.21	3.06	1.70	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	212.99	14.62	6.26	6.26	2.09	0.00	6.26	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	264.01	15.46	9.74	5.73	2.29	6.30	2.86	0.00	0.57	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	227.31	14.80	7.70	4.44	2.07	6.51	2.96	1.18	0.00	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	247.35	28.80	8.47	6.78	0.00	5.08	0.00	1.69	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	282.49	12.43	5.38	4.14	2.90	8.70	4.14	2.49	1.24	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	255.44	17.95	7.82	5.75	1.84	8.05	2.30	2.53	1.15	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	221.28	10.54	0.00	0.00	0.00	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	211.81	9.99	6.92	3.08	1.92	5.00	1.92	0.77	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	203.08	12.39	8.48	3.26	1.30	2.93	1.96	1.30	0.33	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	204.67	16.05	6.02	3.34	2.01	0.67	1.34	0.67	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	204.19	10.79	3.47	7.71	1.93	3.08	2.70	0.77	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	209.17	10.27	6.50	1.71	1.71	2.05	4.11	2.05	0.00	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	208.72	29.82	12.42	0.00	0.00	0.00	2.48	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	259.05	16.04	7.08	3.30	3.30	1.42	1.42	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	203.98	16.90	7.85	4.22	4.22	1.21	3.02	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	196.86	7.63	6.61	7.63	1.53	1.53	3.05	0.00	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	226.54	11.97	9.57	2.39	1.99	3.19	2.79	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	183.03	10.85	11.35	2.47	1.48	3.45	1.97	1.48	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	225.46	9.44	9.44	4.72	2.36	3.54	2.36	2.36	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	205.96	10.50	7.58	1.17	1.17	0.58	0.00	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	190.04	11.41	6.58	1.32	3.07	1.32	1.32	0.44	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	163.60	12.72	9.32	0.85	2.54	4.24	2.54	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	155.79	8.95	8.36	1.19	2.39	2.98	0.60	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	129.56	7.28	4.85	4.85	3.40	4.85	0.97	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	168.91	7.99	3.42	2.28	2.28	0.00	2.28	5.71	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	147.20	4.16	4.99	4.16	2.08	0.83	1.25	1.25	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	204.65	10.12	2.25	5.62	4.50	2.25	2.25	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	79.92	3.81	0.95	0.63	0.95	0.00	1.59	0.00	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	72.27	4.18	1.25	2.92	1.25	0.00	1.25	1.25	0.84	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	442.58	21.93	17.99	7.43	6.50	6.03	9.17	5.22	2.79	1.97
Hep-2 cells mock treated, biol_rep2	11899-125E9	427.57	18.06	15.70	6.25	3.21	5.23	10.13	5.91	1.01	1.86
Hep-2 cells mock treated, biol_rep3	11900-125F1	371.29	16.15	14.56	6.37	3.87	5.23	6.60	4.32	0.91	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	474.62	20.66	14.21	7.54	5.36	4.70	10.17	4.81	1.53	1.42
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	403.82	22.35	14.61	6.88	5.37	7.74	9.24	4.94	2.36	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	354.14	12.06	10.33	6.24	3.88	4.31	6.03	4.09	1.29	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	433.27	20.18	14.82	8.34	4.48	5.85	8.09	4.73	2.37	1.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	398.00	16.47	13.21	7.55	3.77	4.63	7.03	4.80	1.54	1.89
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	348.89	13.14	13.14	6.73	2.24	4.49	7.69	5.13	0.64	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	69.39	7.83	5.04	1.12	1.12	0.00	1.68	3.36	2.24	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	140.23	7.79	3.90	2.60	3.46	0.87	0.87	1.30	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	179.78	0.00	0.00	2.64	2.64	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	132.98	8.47	6.35	3.17	1.76	2.47	0.71	1.06	0.71	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	127.14	5.09	7.99	2.18	1.45	0.73	0.00	1.45	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	188.83	11.01	6.29	4.37	1.57	0.70	3.32	2.10	0.52	0.70
Hepatocyte, donor1	11523-119I2	115.01	2.42	0.00	2.42	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	190.69	6.46	5.39	0.00	1.08	0.00	1.08	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	101.23	0.61	3.68	1.23	1.23	0.61	1.23	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	232.36	13.05	8.48	5.87	1.96	11.10	2.61	0.65	1.31	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	197.85	13.98	3.85	1.40	2.62	5.42	2.45	0.35	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	95.08	6.31	5.35	3.16	1.10	1.65	0.27	1.65	0.55	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	203.77	3.18	6.37	0.00	3.18	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	166.88	6.68	6.68	6.68	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	178.58	5.54	6.92	4.15	5.54	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	212.73	5.01	2.50	5.01	0.00	7.51	5.01	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	332.31	0.00	11.87	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	181.97	2.56	10.25	2.56	2.56	0.00	0.00	2.56	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	191.97	0.00	9.14	4.57	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	251.77	12.99	12.99	3.25	1.62	3.25	3.25	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	191.74	1.67	13.34	1.67	5.00	3.33	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	225.10	0.00	7.26	3.63	3.63	0.00	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	231.61	10.59	7.94	6.62	3.97	3.97	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	219.51	13.30	5.54	1.11	1.11	2.22	2.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	256.68	15.71	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	234.94	6.93	7.56	5.67	1.89	0.00	2.52	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	216.53	6.19	12.37	1.55	1.55	0.00	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	131.71	14.63	0.00	0.00	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	230.64	7.75	7.75	5.17	0.65	3.23	1.94	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	206.07	6.44	8.05	4.83	1.61	1.61	3.22	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	179.22	11.95	11.95	0.00	11.95	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	242.83	4.89	8.15	4.89	0.81	3.26	1.63	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	249.37	4.62	8.40	4.62	3.36	2.94	1.26	0.42	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	57.49	14.37	0.00	0.00	14.37	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	221.82	6.43	12.06	1.61	2.41	2.41	3.21	0.00	0.80	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	201.28	4.62	7.39	3.69	2.77	3.69	7.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	135.73	0.00	0.00	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	221.39	13.69	9.44	2.83	0.47	2.36	2.83	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	175.95	8.16	5.44	2.72	2.72	0.91	2.72	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	132.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	208.77	8.61	9.69	4.30	0.00	5.38	2.15	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	249.01	8.89	7.62	1.27	3.81	0.00	1.27	2.54	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	180.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	174.09	7.65	10.84	0.00	1.91	2.55	1.91	0.64	0.64	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	236.95	7.29	9.11	5.47	0.00	0.00	5.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	268.67	15.80	0.00	15.80	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	184.94	6.43	6.43	2.86	1.43	0.00	2.14	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	182.51	16.59	9.95	0.00	0.00	6.64	0.00	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	145.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	221.62	9.26	4.94	4.01	2.47	1.54	4.63	0.93	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	194.92	1.76	0.00	8.78	1.76	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	172.87	6.29	3.14	6.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	185.67	7.65	8.34	1.39	2.09	2.09	4.17	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	239.01	11.07	6.64	4.43	4.43	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	236.67	12.97	16.21	6.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	190.95	4.36	7.85	4.36	3.49	0.87	3.49	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	186.73	9.00	18.00	2.25	6.75	2.25	0.00	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	250.89	3.48	13.94	3.48	0.00	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	146.15	6.40	9.60	1.07	2.13	1.07	4.27	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	205.05	6.93	15.24	2.77	2.77	1.39	1.39	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	190.92	8.55	2.85	0.00	0.00	2.85	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	206.18	8.28	11.05	1.84	0.92	0.92	3.68	1.84	2.76	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	111.94	6.05	3.03	0.00	3.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	155.22	6.21	18.63	0.00	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	112.08	1.06	3.17	1.06	2.11	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	251.41	7.43	5.14	1.71	1.55	0.49	0.98	0.24	0.24	0.24
Keratinocyte - epidermal, donor2	11349-117G8	187.40	9.37	8.78	1.17	0.00	0.00	0.00	0.00	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	238.91	9.56	7.57	6.91	1.80	0.28	4.26	0.19	0.09	0.19
Keratinocyte - oral, donor1	11251-116E9	357.35	13.74	7.83	3.86	2.84	1.59	2.27	1.14	0.68	0.00
Keratocytes, donor1	11527-119I6	339.02	22.35	13.07	10.31	4.81	0.00	1.03	2.06	0.00	0.34
Keratocytes, donor2	11607-120I5	248.42	11.72	3.52	11.72	2.34	0.00	0.00	2.34	1.17	0.00
Keratocytes, donor3	11688-122I5	135.75	6.52	5.34	1.38	0.99	0.20	1.58	0.40	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	221.99	19.78	6.59	26.37	17.58	2.20	2.20	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	128.37	0.00	2.16	2.16	2.16	0.00	1.08	2.16	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	99.07	7.27	5.77	5.65	4.50	1.96	0.69	0.12	0.23	0.23
Lens Epithelial Cells, donor3	11690-122I7	40.57	2.72	2.93	1.92	1.41	1.41	0.00	0.91	0.30	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	198.73	10.55	4.39	2.73	0.36	0.71	1.19	1.66	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	203.45	10.33	3.07	2.23	1.95	0.28	1.12	1.40	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	178.98	9.13	3.62	2.52	1.10	0.16	2.99	1.57	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	181.21	6.45	1.61	0.54	1.08	0.00	1.08	2.15	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	229.13	11.66	2.84	2.84	0.95	0.00	0.95	3.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	185.66	8.52	2.59	2.48	0.86	0.32	2.37	1.62	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	163.75	4.51	3.28	1.23	0.00	0.00	0.41	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	214.39	9.35	2.53	3.03	1.01	0.51	0.51	3.03	1.01	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	169.60	7.60	2.25	1.83	0.14	0.28	1.55	1.83	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	159.40	5.14	1.98	1.98	0.79	0.00	0.79	1.58	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	203.77	10.08	3.30	3.49	0.97	0.19	1.36	1.74	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	150.90	7.41	3.52	3.52	0.56	0.37	1.48	1.85	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	164.80	5.23	0.70	0.70	1.39	0.00	2.09	2.09	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	214.43	12.40	1.91	0.95	1.19	0.24	0.72	2.86	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	175.12	7.97	2.20	2.20	1.65	0.69	1.65	2.75	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	147.20	5.85	2.16	1.85	1.23	0.00	1.23	1.85	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	235.99	11.85	3.43	2.49	1.56	1.25	1.56	1.25	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	188.11	10.61	3.29	2.38	0.91	1.10	1.46	1.46	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	162.91	6.91	2.96	2.63	0.66	0.66	1.65	1.32	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	244.55	8.49	2.64	2.05	0.59	1.17	2.05	2.34	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	214.58	10.95	2.24	1.49	1.00	0.75	1.99	1.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	165.86	6.79	2.91	1.94	0.97	0.48	0.00	2.42	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	224.59	11.04	1.62	1.35	1.89	0.27	0.81	1.89	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	181.65	6.66	2.27	1.51	0.76	0.00	2.72	2.12	1.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	172.63	6.74	4.15	2.07	1.04	0.52	1.56	2.59	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	205.20	9.42	1.68	2.09	1.05	0.21	1.05	2.72	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	160.75	9.77	3.16	1.50	0.30	0.45	2.26	1.65	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	141.70	11.69	1.38	0.69	1.38	0.00	1.38	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	185.14	7.53	2.07	2.07	0.94	0.38	2.07	1.88	1.51	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	177.39	6.36	3.92	1.38	1.06	0.00	2.23	1.27	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	152.16	5.81	1.45	1.94	0.00	0.48	2.42	1.94	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	189.87	7.94	1.32	2.65	0.33	0.00	1.32	3.64	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	153.50	7.06	2.48	1.49	0.62	0.25	1.98	2.35	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	178.44	4.07	1.85	1.11	1.11	0.37	0.37	1.48	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	203.84	6.18	1.73	2.22	0.74	0.00	1.48	3.46	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	162.52	7.97	2.89	2.61	0.82	0.27	0.82	1.51	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	135.41	5.15	2.57	0.32	1.61	0.00	0.00	1.29	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	213.94	11.26	1.52	1.83	0.30	0.30	1.22	2.43	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	157.60	6.30	2.38	1.40	1.68	0.70	1.26	2.94	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	119.82	5.33	1.42	0.36	2.49	0.00	0.00	1.07	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	223.97	10.67	0.97	1.94	2.42	0.00	1.45	0.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	173.81	7.78	3.73	2.33	0.47	0.31	1.40	2.33	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	158.64	6.80	2.86	1.79	0.36	0.36	2.51	1.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	194.70	10.45	1.31	1.63	0.33	0.00	0.98	1.63	0.65	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	156.56	6.59	1.88	1.41	1.41	0.00	1.41	1.18	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	172.39	9.28	3.09	1.73	1.36	0.37	1.24	1.49	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	214.38	6.92	4.10	1.54	0.26	0.51	1.02	1.79	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	156.04	7.46	2.39	1.19	1.49	1.79	1.19	1.19	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	401.08	15.86	11.33	2.27	4.53	4.53	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	268.50	15.34	6.14	8.44	3.84	3.84	3.07	1.53	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	218.96	11.13	3.71	9.65	3.71	5.94	1.48	1.48	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	265.72	9.31	4.23	5.08	7.19	2.96	2.12	1.69	1.27	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	227.17	14.07	5.63	9.14	4.92	2.11	4.92	1.41	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	214.81	12.14	4.67	4.67	3.74	2.80	0.93	1.87	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	209.20	9.79	3.61	8.76	4.64	5.15	2.06	0.52	1.03	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	181.99	11.89	4.76	4.76	1.19	5.95	4.76	1.19	0.00	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	225.51	13.80	5.65	4.75	4.75	2.49	1.58	0.68	2.04	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	259.13	12.21	3.78	6.40	3.20	3.49	4.07	1.45	2.62	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	259.30	18.91	4.05	8.10	4.95	2.70	5.40	1.35	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	291.02	16.53	7.18	5.15	3.25	2.30	1.49	1.35	0.81	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	276.79	11.81	6.16	8.73	4.62	4.62	1.03	1.54	1.54	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	237.82	14.11	7.76	7.06	4.59	3.18	4.59	1.41	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	227.21	11.33	3.33	4.00	1.33	5.33	3.33	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	276.60	14.77	5.60	5.09	3.06	3.57	3.06	2.04	0.51	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	251.06	15.21	8.27	8.54	5.34	5.60	5.34	1.87	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	278.32	13.98	8.69	10.58	6.24	2.83	5.10	0.76	1.32	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	249.72	12.27	4.29	3.68	5.52	1.23	1.84	0.61	3.07	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	310.68	22.02	8.97	6.52	3.26	2.45	2.45	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	272.38	15.62	8.12	8.33	3.75	5.00	4.58	1.04	0.62	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	293.15	14.01	6.73	5.89	5.32	4.48	2.52	0.84	1.40	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	254.49	14.42	6.18	4.12	2.06	4.12	2.06	2.06	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	279.27	15.97	5.81	8.13	3.19	5.23	4.94	2.90	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	260.67	15.54	4.48	7.47	3.59	2.99	2.69	2.09	1.79	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	242.88	15.49	7.75	8.30	3.32	3.32	5.53	2.21	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	278.90	12.02	6.72	8.48	4.95	4.24	2.12	1.41	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	273.27	14.38	5.90	5.90	4.43	3.69	4.06	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	223.35	10.36	13.82	12.66	5.76	5.76	3.45	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	266.32	18.04	3.84	7.29	4.99	2.69	2.30	2.69	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	277.40	13.02	1.70	6.23	1.13	5.10	6.23	1.13	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	260.91	9.85	9.03	7.38	3.28	1.64	4.92	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	263.90	11.75	7.23	8.13	2.71	3.62	5.42	1.81	0.90	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	291.57	13.64	2.87	6.46	3.59	2.87	2.87	0.72	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	267.39	17.93	9.71	5.98	5.23	2.99	5.98	1.49	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	271.26	8.18	7.06	7.80	4.83	2.23	6.32	1.11	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	245.10	15.08	5.17	6.89	5.17	5.17	3.88	1.29	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	280.01	18.84	6.85	7.71	3.43	5.99	1.71	1.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	328.51	16.33	11.99	7.00	6.33	3.66	6.00	1.67	1.00	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	273.90	14.48	4.83	10.86	5.43	4.22	1.21	0.60	3.62	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	235.34	22.75	4.27	10.66	2.13	6.40	2.13	2.13	2.13	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	278.41	14.44	7.91	7.22	3.44	4.81	5.16	1.72	1.03	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	273.20	11.27	3.76	8.05	4.83	3.76	2.68	3.76	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	259.92	13.47	10.77	6.73	2.69	1.35	4.04	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	291.14	17.04	5.93	12.22	3.33	4.44	3.33	1.11	1.48	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	443.08	19.77	8.14	10.47	4.65	2.33	1.16	2.33	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	207.32	12.69	10.58	8.46	4.23	4.23	2.12	2.12	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	276.10	16.41	5.20	8.00	6.40	4.00	4.40	0.80	1.20	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	230.42	14.54	6.54	6.54	1.45	5.09	2.18	2.91	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	241.45	15.33	9.20	10.73	5.37	3.83	3.83	0.00	1.53	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	259.46	14.31	8.88	8.39	2.47	4.44	3.95	1.97	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	256.87	15.05	4.70	5.65	2.82	2.82	0.00	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	238.34	15.59	9.05	5.03	3.02	3.52	3.02	0.50	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	241.08	10.36	4.96	7.66	5.41	2.70	4.96	0.90	0.90	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	203.09	13.77	5.16	6.88	5.16	3.44	3.44	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	241.38	18.70	11.13	9.80	2.23	3.12	5.34	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	292.49	14.47	7.04	6.26	4.30	2.74	3.52	1.17	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	234.21	12.53	2.64	4.62	3.30	3.96	4.62	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	263.10	16.09	7.78	8.30	4.67	4.67	6.23	1.04	2.08	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	309.80	14.88	7.00	8.31	3.50	2.63	4.81	0.88	1.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	248.80	14.54	4.47	5.03	4.47	4.47	1.68	2.24	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	257.48	18.99	5.74	7.51	4.86	3.97	5.30	1.32	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	261.90	13.89	5.79	7.71	3.47	4.24	5.01	0.77	1.54	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	260.27	11.65	4.56	5.06	3.04	2.03	3.54	2.53	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	253.29	10.09	5.29	5.77	2.88	1.44	2.88	1.92	1.44	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	271.13	10.34	9.54	6.76	4.77	7.16	2.78	1.19	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	230.90	10.33	6.08	7.29	3.04	4.25	1.22	1.82	2.43	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	157.02	14.53	4.15	4.84	0.69	6.92	2.77	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	248.13	17.48	4.94	6.84	3.04	4.94	3.04	1.14	1.52	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	258.21	13.43	3.61	6.71	6.71	3.10	3.61	2.58	1.03	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	167.49	12.70	7.86	7.26	3.02	2.42	1.21	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	270.95	13.63	7.29	7.92	5.07	3.17	5.39	1.58	0.63	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	234.03	12.26	4.26	5.86	4.80	2.13	3.20	2.13	1.60	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	156.31	15.52	3.45	1.72	4.02	3.45	1.15	1.72	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	251.97	14.91	9.26	7.20	3.60	3.60	4.11	2.57	0.51	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	290.72	13.44	7.07	6.37	1.41	2.83	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	166.27	14.19	8.51	3.40	1.70	1.70	2.84	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	236.30	11.23	6.24	9.57	1.25	7.07	5.82	0.42	0.42	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	272.50	6.26	5.48	7.83	2.35	7.05	2.35	1.57	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	174.12	17.12	6.68	2.92	3.34	2.51	2.92	2.51	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	261.13	13.47	3.25	8.36	3.25	1.86	6.04	0.93	0.00	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	251.56	10.70	3.35	10.04	4.01	2.68	2.01	1.34	0.00	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	184.99	13.37	4.81	5.88	1.60	1.07	1.60	1.60	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	284.89	8.89	6.87	8.08	5.25	4.85	4.45	1.62	0.81	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	214.76	11.93	2.75	9.18	2.75	3.67	0.92	3.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	155.59	9.78	4.45	7.11	0.00	3.56	0.89	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	241.62	20.52	7.41	9.69	3.99	3.99	1.71	1.71	0.57	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	262.28	9.97	3.07	3.07	0.77	5.37	3.07	2.30	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	204.10	18.60	6.57	4.92	4.38	3.83	2.74	1.64	0.00	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	256.13	12.92	6.24	8.91	2.23	4.45	1.34	1.34	0.00	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	300.77	15.34	4.42	5.98	5.20	4.68	1.30	0.26	0.52	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	202.91	15.91	8.62	4.64	3.32	3.98	0.66	0.00	1.33	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	322.18	10.39	10.39	10.39	8.31	8.31	4.16	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	52.65	1.60	3.65	0.91	1.37	0.00	0.68	0.46	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	52.48	2.02	2.94	0.92	0.92	0.18	0.18	1.65	0.55	0.18
Macrophage - monocyte derived, donor3	11389-118C3	77.86	3.54	5.51	3.28	1.05	0.13	1.57	2.10	0.39	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	104.08	4.25	2.66	1.06	0.53	0.00	1.06	1.59	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	120.74	3.64	3.96	0.79	1.43	1.27	0.16	0.95	0.79	1.11
Mallassez-derived cells, donor3	11930-125I4	231.55	5.56	5.28	2.36	1.39	0.83	1.53	1.39	0.56	0.97
Mammary Epithelial Cell, donor1	11273-116H4	238.05	7.37	7.67	4.28	2.89	1.10	1.00	0.60	0.40	0.20
Mammary Epithelial Cell, donor2	11350-117G9	234.25	8.11	5.50	6.08	2.03	0.29	0.87	0.87	1.16	0.00
Mammary Epithelial Cell, donor3	11422-118F9	187.82	6.49	7.73	3.24	1.75	0.75	1.25	2.24	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	46.78	0.00	1.36	2.03	1.36	0.00	0.00	1.36	0.00	0.00
Mast cell, donor1	11563-120D6	52.88	4.33	6.49	2.92	1.41	0.22	0.11	0.65	0.32	0.00
Mast cell, donor2	11565-120D8	54.68	2.97	8.92	2.08	2.08	0.00	0.30	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	53.58	1.80	10.36	1.58	2.25	0.45	0.23	0.23	0.23	0.00
Mast cell, donor4	11567-120E1	51.59	1.95	10.28	0.89	1.24	0.00	0.53	0.53	0.18	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	49.46	2.33	4.88	2.99	2.22	0.44	0.67	0.44	0.22	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	78.21	5.84	2.92	2.33	1.75	0.00	0.00	2.33	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	51.28	2.29	5.85	1.72	1.84	0.11	0.34	0.57	0.69	0.00
Mast cell, expanded, donor8	11941-126A6	117.99	5.86	7.03	2.34	1.51	0.50	0.84	2.34	0.50	0.00
Melanocyte - dark, donor1	11502-119F8	115.72	6.27	5.37	1.99	1.19	0.70	0.50	1.79	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	152.97	6.58	3.46	3.11	0.00	0.00	2.08	0.69	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	45.57	3.11	5.07	2.03	1.96	0.00	0.29	0.72	0.00	0.07
Melanocyte - light, donor1	11274-116H5	41.37	1.41	3.29	2.12	1.18	0.00	0.47	0.00	0.00	0.24
Melanocyte - light, donor2	11351-117H1	61.42	3.41	3.41	1.36	1.36	0.00	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	55.50	8.67	1.73	6.07	0.87	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	86.63	3.96	5.62	1.35	2.08	0.10	2.39	0.62	0.10	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	89.02	3.77	2.96	3.23	2.42	0.27	2.42	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	66.70	3.21	4.55	1.87	0.80	0.00	1.07	0.00	0.54	0.00
Meningeal Cells, donor1	11493-119E8	106.57	13.15	6.82	7.57	2.11	0.50	0.12	0.37	0.37	0.25
Meningeal Cells, donor2	11573-120E7	57.66	7.48	5.28	6.60	1.76	0.44	0.44	1.32	0.00	0.00
Meningeal Cells, donor3	11654-122E7	156.73	10.43	4.24	6.52	0.98	0.49	0.82	1.30	0.16	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	146.57	12.55	6.27	6.84	3.71	0.29	1.43	1.14	1.14	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	93.69	4.83	2.01	1.61	2.01	0.60	0.00	1.01	0.50	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	91.99	9.20	2.63	0.00	0.00	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	240.70	11.77	6.54	5.23	0.00	0.00	1.31	2.62	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	152.85	5.74	4.31	2.87	0.00	0.72	0.72	2.15	1.44	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	68.19	4.02	2.75	2.33	1.69	0.85	0.00	0.64	0.42	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	87.46	8.04	3.52	1.51	1.51	0.00	0.50	2.01	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	156.90	11.87	5.27	5.49	3.96	0.88	0.44	1.32	0.66	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	141.73	15.34	4.38	10.96	5.84	0.00	2.92	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	165.73	8.80	6.34	8.80	3.89	0.00	2.05	0.82	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	41.28	4.16	4.71	0.83	2.35	0.28	0.83	0.14	0.42	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	96.65	7.43	2.97	1.12	2.23	0.37	0.37	1.12	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	92.50	5.66	2.50	0.92	2.37	0.26	0.53	0.53	0.26	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	76.26	3.56	4.15	1.19	2.97	0.89	0.00	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	93.42	4.67	0.00	2.34	0.00	0.00	4.67	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	215.81	10.89	8.97	5.12	2.56	0.64	3.84	1.28	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	162.69	6.73	8.51	3.90	1.77	0.35	0.71	1.77	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	81.00	2.81	3.13	1.25	2.81	0.00	1.56	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	194.49	10.89	7.26	5.08	1.45	0.73	3.63	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	92.28	3.71	3.71	1.86	2.39	1.59	0.53	1.86	1.33	0.00
Mesothelial Cells, donor2	12156-128G5	70.57	5.51	1.50	1.50	4.00	1.50	0.00	0.50	1.50	0.00
Mesothelial Cells, donor3	11402-118D7	78.48	3.83	3.18	1.81	2.46	0.94	0.65	1.23	0.65	0.87
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	97.22	4.05	2.70	0.00	4.05	0.00	0.00	5.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	52.21	2.22	2.71	0.99	0.99	0.25	0.49	3.69	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	58.89	1.18	3.83	0.59	0.88	0.59	0.59	3.24	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	55.31	0.00	10.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	38.12	0.00	2.48	0.62	0.93	0.00	0.31	3.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	39.83	2.28	1.45	1.87	1.45	0.00	0.21	1.24	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	44.00	2.32	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	54.81	1.25	5.51	0.50	1.75	0.50	0.50	2.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	50.74	2.79	2.33	1.40	0.47	0.47	0.00	4.19	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	155.73	0.00	0.00	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	47.35	2.24	3.66	1.22	1.02	0.41	0.81	0.61	0.20	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	50.29	1.19	2.38	0.40	1.58	0.00	0.00	3.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	8.55	0.00	0.00	0.00	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	37.17	0.00	0.88	1.77	1.77	0.00	1.77	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	58.13	1.52	1.90	1.52	0.76	1.14	0.38	1.14	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	46.06	1.32	0.00	3.95	0.00	0.00	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	40.75	1.27	1.70	0.64	0.42	0.00	0.64	1.49	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	35.91	2.76	1.84	2.76	0.00	0.00	0.00	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	41.13	0.30	2.38	0.60	0.60	0.30	0.60	0.89	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	53.65	3.35	3.35	1.68	5.03	0.00	1.68	3.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	45.92	1.25	3.26	0.75	1.25	0.50	0.25	0.75	0.50	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	51.57	1.90	1.43	1.43	1.66	0.71	0.24	2.14	0.24	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	35.94	2.21	1.66	1.11	0.55	0.00	0.00	1.11	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	49.73	1.61	2.76	0.69	0.92	0.00	0.46	0.69	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	37.65	1.26	1.47	0.63	1.68	0.21	0.21	1.47	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	37.10	0.82	1.43	0.00	0.41	0.20	0.61	1.22	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	38.40	1.07	1.72	0.86	0.64	0.21	0.43	0.86	0.64	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	38.90	2.00	1.56	1.11	1.33	0.44	0.22	1.78	0.67	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	28.91	0.66	2.19	0.22	0.44	0.44	0.00	0.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	28.39	2.03	2.03	0.00	0.00	0.51	0.00	2.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	41.42	0.00	1.66	0.00	1.66	0.00	0.00	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	42.13	1.36	2.72	1.09	1.09	0.00	0.82	1.63	1.09	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	39.70	2.06	1.18	0.29	1.47	0.29	0.29	1.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	29.44	0.00	0.00	1.09	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	34.60	2.40	3.36	0.96	0.96	0.00	0.00	0.48	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	45.63	1.60	2.00	0.00	1.20	0.40	0.00	2.40	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	28.80	0.00	0.00	0.00	1.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	45.55	2.00	1.50	0.50	0.00	0.50	0.00	1.00	1.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	34.65	0.00	0.00	0.00	2.04	2.04	0.00	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	37.66	2.63	2.19	0.44	1.31	0.44	0.44	3.07	0.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	26.49	4.41	2.21	4.41	1.10	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	40.98	0.00	1.28	0.00	0.64	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	50.33	2.23	2.48	0.00	0.99	0.50	0.25	1.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	28.53	2.09	1.39	2.09	1.39	0.00	0.00	2.09	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	66.30	0.00	2.21	0.00	2.21	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	86.49	2.39	2.05	0.68	0.68	0.00	0.00	0.68	1.03	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	39.82	1.31	1.75	0.00	1.31	0.00	0.00	1.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	65.34	0.36	0.71	2.13	1.07	0.00	0.00	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	79.68	3.65	2.52	1.12	1.68	0.00	0.56	1.68	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	47.38	1.66	3.74	0.42	1.25	0.42	0.42	2.49	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	57.11	3.50	1.75	1.75	1.75	1.17	0.58	1.75	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	87.18	3.32	2.11	0.90	1.21	0.00	0.30	0.60	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	63.44	2.50	4.59	0.00	1.25	0.00	0.83	3.34	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	21.66	7.22	0.00	0.00	0.00	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	101.59	2.77	2.77	0.92	0.92	0.00	0.92	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	71.71	2.28	1.71	1.14	0.57	0.00	1.14	2.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	79.45	2.76	3.73	0.69	1.52	0.28	0.41	1.66	0.83	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	99.51	2.85	1.55	0.78	2.07	0.26	0.52	2.33	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	60.91	3.00	3.00	0.86	0.00	0.00	0.43	3.00	0.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	74.32	5.08	2.54	1.91	1.91	0.00	0.00	1.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	98.75	4.00	2.40	0.00	1.07	0.00	0.00	1.60	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	79.02	1.50	4.79	1.50	1.50	0.00	0.00	2.39	0.90	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	87.15	2.54	3.81	0.71	0.28	0.57	0.14	0.99	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	105.43	2.55	3.50	0.00	0.64	0.32	0.00	3.82	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	76.51	2.87	3.32	0.66	1.55	0.44	0.66	3.32	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	91.39	2.28	4.17	0.76	2.28	0.00	0.00	1.14	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	104.84	2.84	6.25	0.57	1.42	0.00	0.00	1.99	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	84.06	4.42	4.42	0.98	0.74	0.49	1.23	2.95	0.98	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	87.98	2.61	3.26	0.65	2.61	0.00	0.65	0.65	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	126.73	2.65	3.53	0.29	1.18	0.29	1.76	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	104.66	3.46	5.19	0.58	2.02	0.00	0.58	3.46	0.86	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	132.71	3.30	7.01	1.24	0.41	0.00	0.82	1.24	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	133.11	3.57	2.38	0.89	2.08	0.00	0.30	2.08	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	60.27	3.77	0.00	0.00	3.77	0.00	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	67.73	1.78	3.56	0.00	1.78	0.00	1.78	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	112.04	2.63	2.96	0.00	2.30	0.00	1.31	1.64	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	106.25	3.16	6.31	0.00	1.05	0.00	2.10	3.16	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	75.32	3.36	4.15	1.38	1.58	0.00	0.20	0.79	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	49.36	5.59	1.86	0.00	0.00	0.93	0.00	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	52.57	1.88	3.38	0.75	0.75	0.00	1.13	2.25	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	59.39	1.33	5.86	1.33	1.07	0.00	0.80	1.86	0.53	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	67.07	1.92	3.05	0.00	0.57	0.00	0.68	1.24	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	57.46	4.42	2.21	0.74	1.47	0.00	0.00	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	100.03	1.83	3.30	1.10	2.20	0.37	1.83	1.10	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	79.34	9.33	0.00	0.00	0.00	1.56	3.11	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	25.65	0.53	1.60	0.00	0.00	0.00	0.00	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	57.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	90.89	1.01	5.05	3.03	4.04	0.00	0.00	5.05	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	40.48	0.84	1.69	0.42	0.00	0.00	0.00	1.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	14.98	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	0.00	0.64	0.00	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	5.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	74.23	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	0.00	3.26	0.00	3.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	47.52	4.75	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	60.75	4.74	1.72	1.51	0.00	0.00	0.22	1.29	0.65	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	120.72	6.79	3.66	3.14	1.57	1.05	0.52	1.57	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	76.09	2.67	2.00	4.00	4.67	0.00	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	115.19	7.51	1.67	4.59	1.25	0.00	0.00	1.25	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	238.25	7.61	6.46	7.23	2.66	0.76	1.33	2.66	0.19	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	303.21	19.15	11.17	15.96	3.19	1.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	67.31	5.44	0.00	4.08	3.40	0.68	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	130.47	1.84	1.84	3.68	1.84	0.00	1.84	0.00	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	90.40	10.04	1.67	3.77	3.35	0.84	0.00	0.42	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	177.82	7.44	3.25	6.04	2.79	0.93	0.00	1.86	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	109.17	6.22	1.08	2.97	2.70	0.54	0.54	0.81	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	117.10	7.57	3.99	3.36	0.42	0.21	0.42	0.63	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	178.16	0.00	0.00	11.13	0.00	0.00	0.00	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	81.40	9.93	0.50	2.48	1.99	0.50	0.00	0.00	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	143.18	2.98	3.25	0.81	1.35	0.81	0.81	1.89	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	99.97	4.53	1.36	1.59	2.49	0.00	0.23	1.13	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	101.90	5.06	3.10	0.49	1.47	0.16	0.00	0.98	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	119.56	3.10	3.10	0.91	1.28	0.18	0.91	0.91	0.36	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	68.96	1.06	1.06	0.53	1.59	0.00	0.00	0.53	1.59	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	103.25	6.60	2.40	0.00	2.40	0.00	0.00	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	174.59	4.27	7.22	0.98	0.66	0.66	0.00	1.97	1.64	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	90.91	3.58	2.11	0.49	1.46	0.65	0.00	0.98	0.49	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	150.81	6.35	3.53	2.12	2.47	0.18	0.53	0.88	1.23	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	92.12	5.63	0.00	2.11	2.11	0.70	0.00	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	158.14	1.84	2.76	0.92	0.92	1.38	0.46	2.30	0.00	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	103.15	6.43	0.96	1.93	1.93	0.64	0.64	1.29	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	127.61	2.41	3.45	0.34	1.03	0.69	0.34	4.48	0.69	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	151.71	5.06	2.53	0.00	0.00	0.00	7.59	7.59	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	117.41	5.12	2.45	1.56	1.56	0.22	0.00	0.89	0.45	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	123.63	5.50	2.12	0.85	1.27	0.00	0.00	0.85	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	160.69	2.37	2.85	0.47	2.37	0.95	0.24	2.61	0.24	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	89.28	6.44	4.29	3.00	3.43	0.43	0.43	1.29	0.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	0.00	9.03	0.00	0.00	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	61.31	4.67	0.67	1.00	4.33	1.33	0.00	1.00	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	113.17	4.96	2.25	0.90	2.71	0.90	0.00	2.25	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	81.74	5.95	1.59	1.59	1.59	0.79	0.79	1.19	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	117.94	3.71	2.79	1.86	0.93	0.93	0.00	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	115.40	3.78	3.41	2.65	3.41	0.76	1.14	0.76	0.38	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	72.67	8.47	0.00	0.98	1.96	0.00	0.00	1.63	0.98	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	46.63	3.49	0.00	0.44	2.61	0.00	0.00	0.87	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	119.40	5.88	3.17	0.90	3.17	0.90	0.45	2.26	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	76.73	8.82	0.88	0.00	3.53	0.00	0.00	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	97.73	3.99	0.00	1.33	1.33	1.33	0.00	1.99	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	56.55	5.46	0.99	0.50	5.46	0.50	0.50	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	59.72	4.98	0.38	1.15	1.91	0.77	0.38	0.38	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	111.90	3.33	3.63	2.12	4.84	0.60	1.21	2.12	0.60	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	101.23	4.86	2.43	0.66	2.21	0.88	0.44	1.11	0.66	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	79.96	3.39	0.00	1.36	2.03	0.00	0.00	0.68	0.68	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	143.07	0.00	10.22	0.00	0.00	0.00	0.00	0.00	5.11	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	74.99	4.88	1.22	0.61	2.44	0.00	0.61	1.22	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	70.50	4.09	2.20	1.26	3.15	0.31	0.00	0.63	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	86.56	3.03	0.91	0.61	1.51	0.30	0.30	2.12	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	71.20	3.16	0.79	0.79	1.58	0.79	0.79	2.37	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	126.97	2.27	0.00	0.00	0.00	0.00	0.00	6.80	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	116.33	0.00	0.00	0.00	0.00	0.00	10.12	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	105.72	4.35	2.11	2.36	1.37	0.62	0.62	0.99	1.37	0.25
Myoblast, donor2	11322-117D8	187.57	8.25	3.45	2.88	3.07	0.77	1.34	2.11	1.34	0.38
Myoblast, donor3	11398-118D3	107.96	6.89	3.87	5.38	2.35	1.18	0.50	1.35	0.67	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	103.03	9.92	5.40	3.21	0.88	0.58	1.02	0.29	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	69.50	2.15	4.00	0.92	0.62	0.31	0.31	0.31	0.62	0.00
Natural Killer Cells, donor2	11311-117C6	77.80	2.11	3.62	2.11	2.41	0.00	2.11	0.60	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	58.71	2.58	4.05	0.74	1.47	0.55	1.29	0.00	0.18	0.18
Neural stem cells, donor1	11275-116H6	129.93	5.08	4.36	4.72	4.72	0.00	0.73	1.09	0.36	0.36
Neural stem cells, donor2	11352-117H2	59.69	9.63	3.85	1.93	5.78	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	142.24	10.24	4.55	3.41	2.28	0.00	2.28	1.14	0.00	1.14
Neurons, donor2	11574-120E8	68.03	6.83	7.49	1.98	1.10	0.22	0.66	0.22	0.44	0.44
Neurons, donor3	11655-122E8	166.08	16.44	7.40	9.04	7.40	0.82	4.11	1.64	0.82	0.82
Neutrophils, donor1	11233-116C9	72.38	1.86	7.42	0.00	0.93	0.00	1.86	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	57.98	0.00	2.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	45.20	1.22	9.16	0.00	0.00	0.00	0.61	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	94.51	4.63	4.87	1.54	2.02	2.61	1.19	0.47	0.24	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	92.15	2.60	3.58	2.60	2.28	0.65	1.63	0.65	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	51.14	5.62	3.41	1.20	1.20	0.00	0.80	0.60	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	131.32	7.57	1.93	2.20	2.48	1.38	2.20	1.38	0.41	0.41
Olfactory epithelial cells, donor2	11934-125I8	191.35	10.57	3.47	3.91	3.47	1.59	4.20	2.03	1.01	0.72
Olfactory epithelial cells, donor3	11935-125I9	134.39	5.90	3.29	4.54	3.41	2.27	2.27	1.36	1.25	0.57
Olfactory epithelial cells, donor4	11936-126A1	115.22	5.36	3.80	2.14	2.92	1.17	0.88	0.97	0.39	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	129.99	4.81	12.04	4.81	1.20	1.20	0.60	1.81	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	84.65	7.66	3.83	2.34	2.55	0.64	0.43	0.64	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	58.30	0.00	0.00	1.14	5.72	0.00	9.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	68.90	5.59	1.24	1.86	3.72	0.00	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	200.52	12.51	4.10	10.75	5.47	1.56	0.39	1.76	0.98	0.78
Osteoblast, donor2	11354-117H4	125.01	10.53	6.32	2.81	4.21	0.70	2.81	2.81	1.40	0.00
Osteoblast, donor3	11426-118G4	142.18	8.71	6.75	8.71	6.75	0.71	1.24	2.31	0.71	0.53
Pancreatic stromal cells, donor1	11249-116E7	181.70	7.24	2.78	3.62	1.10	0.76	1.35	1.10	0.67	0.17
Pericytes, donor1	11491-119E6	69.10	8.79	8.12	2.89	1.89	0.45	0.67	0.45	0.22	0.00
Pericytes, donor2	11571-120E5	51.39	8.38	4.53	1.81	3.62	0.45	1.13	0.91	0.23	0.00
Pericytes, donor3	11652-122E5	120.24	6.31	3.46	2.24	2.85	0.61	1.42	1.42	0.61	0.00
Perineurial Cells, donor1	11499-119F5	95.50	7.80	6.89	5.43	1.13	0.90	0.79	0.68	0.00	0.00
Perineurial Cells, donor2	11579-120F4	128.45	5.61	4.51	3.40	0.92	0.28	0.18	1.10	0.55	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	84.15	2.23	5.74	0.96	1.91	0.32	0.96	0.00	0.96	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	67.58	3.43	5.14	1.22	0.98	0.00	1.96	0.24	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	67.30	2.46	5.56	0.00	0.91	0.13	1.04	0.13	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	236.54	9.57	9.33	3.11	8.13	2.39	1.20	0.96	0.24	0.96
Placental Epithelial Cells, donor2	11355-117H5	112.00	12.20	3.33	2.22	3.33	3.33	0.00	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	139.00	10.41	4.52	6.87	2.55	0.59	2.36	0.59	0.59	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	44.62	0.63	2.22	1.90	1.90	0.63	0.63	2.22	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	68.28	3.38	1.88	0.94	2.63	0.38	0.00	1.88	1.50	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	25.97	1.57	2.35	0.78	1.31	1.17	0.26	2.09	1.04	0.52
Preadipocyte - breast, donor2	11328-117E5	63.27	3.15	3.15	1.80	2.03	0.68	1.58	2.70	1.58	0.23
Preadipocyte - omental, donor1	11468-119C1	84.18	2.34	2.02	1.28	2.13	1.28	0.21	0.53	1.70	0.75
Preadipocyte - omental, donor2	11329-117E6	71.58	1.31	3.93	1.31	3.49	0.00	0.00	1.31	1.31	0.87
Preadipocyte - omental, donor3	11403-118D8	67.33	4.01	1.86	1.86	3.44	0.86	0.57	2.58	1.00	1.29
Preadipocyte - perirenal, donor1	11469-119C2	36.42	2.95	5.91	1.97	3.94	3.94	0.00	3.94	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	131.45	6.76	3.38	3.38	2.15	1.23	0.92	0.61	0.61	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	233.03	9.21	5.67	7.79	2.48	1.24	3.72	2.48	0.53	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	128.22	4.43	3.75	3.58	3.07	1.70	2.04	1.53	0.51	0.00
Preadipocyte - visceral, donor1	11280-116I2	180.15	10.25	4.28	6.24	2.70	1.40	0.28	1.49	1.21	0.47
Preadipocyte - visceral, donor2	11357-117H7	204.32	7.36	1.84	5.52	1.84	0.00	2.76	1.84	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	93.83	5.22	2.51	3.34	1.57	1.57	2.40	1.88	0.52	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	188.41	18.40	3.02	1.66	4.22	6.03	2.11	0.45	0.45	0.45
Prostate Epithelial Cells, donor2	11331-117E8	80.16	2.44	2.84	1.08	1.35	1.49	1.35	0.81	0.14	0.14
Prostate Epithelial Cells, donor3	11404-118D9	95.22	5.39	3.74	1.22	1.90	0.61	1.41	0.37	0.18	0.06
Prostate Stromal Cells, donor1	11254-116F3	145.00	6.61	2.85	3.64	2.05	0.34	1.14	1.03	0.23	0.23
Prostate Stromal Cells, donor2	11332-117E9	143.08	7.17	2.87	4.66	1.08	0.36	2.87	1.26	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	60.48	4.07	1.98	2.09	1.88	0.83	1.04	0.52	0.63	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	270.45	15.69	9.85	5.47	4.74	4.01	1.46	2.19	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	124.69	5.61	4.99	1.87	1.66	2.43	0.49	0.49	0.55	0.42
Renal Epithelial Cells, donor1	11517-119H5	292.16	27.90	12.68	11.67	6.09	3.04	0.00	1.52	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	270.30	14.23	4.27	7.82	3.56	4.27	1.42	1.42	1.42	4.27
Renal Epithelial Cells, donor3	11678-122H4	156.47	6.25	4.66	2.96	3.49	3.71	0.74	0.64	0.42	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	85.11	13.62	4.77	2.72	0.68	0.68	3.40	1.36	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	108.08	10.38	4.85	4.18	1.35	0.54	2.43	3.50	0.27	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	173.17	7.55	3.77	4.44	1.55	0.89	1.33	2.66	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	123.11	8.65	4.66	2.00	1.33	0.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	126.33	10.56	7.04	6.82	3.30	3.52	0.66	0.88	1.32	0.22
Renal Mesangial Cells, donor2	11598-120H5	122.89	8.78	3.76	2.51	1.88	0.63	1.88	2.51	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	137.60	8.88	3.05	3.33	1.39	2.77	1.11	1.66	0.28	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	260.91	16.91	12.88	7.25	6.44	4.03	1.07	2.15	1.07	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	257.65	16.87	3.37	4.22	2.95	2.11	2.11	2.11	1.27	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	221.00	14.08	8.68	6.75	2.51	3.66	4.63	0.77	0.19	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	150.38	8.82	9.85	4.41	5.44	1.30	2.07	2.85	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	118.53	9.10	6.54	2.27	2.84	1.42	0.00	1.99	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	191.42	6.17	10.29	3.09	4.12	0.00	1.03	2.06	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	138.75	4.77	2.01	0.25	3.26	0.25	0.00	0.75	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	149.14	7.35	6.68	2.41	2.27	0.67	0.67	0.53	0.27	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	176.89	6.25	3.57	1.79	1.79	2.68	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	142.55	1.65	4.40	0.55	1.65	1.65	0.55	1.65	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	237.24	2.90	5.80	0.58	1.74	0.00	0.58	0.58	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	128.07	5.98	11.31	2.34	2.21	1.30	0.91	1.04	0.52	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	263.66	10.53	8.24	3.57	2.48	1.09	1.79	1.79	0.50	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	265.69	9.59	13.16	3.68	3.01	1.12	0.33	1.12	0.67	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	205.79	8.43	16.50	1.61	2.48	1.61	4.59	1.74	0.37	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	297.07	10.84	10.61	3.38	3.73	1.28	3.50	0.93	0.23	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	294.69	8.32	9.25	3.70	3.70	0.46	3.24	1.85	0.69	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	140.88	9.31	8.63	2.60	1.51	0.68	0.82	0.96	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	265.03	10.29	5.60	3.03	2.12	1.06	4.08	1.06	0.45	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	248.00	10.03	9.68	2.87	2.51	1.61	1.43	1.08	0.72	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	142.17	9.76	10.47	2.73	0.86	1.43	2.58	1.58	0.14	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	268.61	8.91	8.80	3.22	3.00	1.18	3.65	0.75	0.75	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	263.09	10.18	9.29	2.88	2.88	1.11	4.20	0.89	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	137.07	6.31	10.13	1.91	0.96	1.53	1.53	2.10	0.38	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	256.38	8.76	8.66	3.63	3.26	1.12	1.21	0.84	0.19	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	286.93	9.02	7.33	3.19	3.57	0.56	0.75	1.50	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	135.49	6.90	10.09	2.26	2.26	1.06	1.59	0.93	0.66	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	255.91	9.05	7.98	4.67	2.63	0.78	2.82	1.56	0.19	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	258.37	12.03	10.69	4.20	2.10	0.76	3.25	2.29	0.95	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	132.21	6.62	8.22	2.78	1.28	0.96	1.39	0.85	0.53	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	263.77	5.33	7.01	3.08	2.80	1.12	5.33	1.40	0.84	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	288.65	9.74	7.35	2.56	2.73	1.71	2.22	0.68	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	121.07	6.93	8.93	2.01	1.09	1.09	1.09	1.64	0.73	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	252.62	8.95	6.99	3.31	2.82	1.10	1.47	1.35	0.61	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	260.45	7.92	9.27	2.55	2.69	0.40	4.03	0.94	0.40	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	137.51	8.73	8.73	2.59	1.42	1.42	1.42	2.12	1.18	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	255.75	9.52	6.94	3.57	2.58	0.60	2.18	0.60	0.79	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	266.82	8.89	7.48	3.51	1.64	1.40	3.74	1.40	0.47	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	134.16	8.09	9.75	3.32	2.07	1.04	1.45	0.83	0.41	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	284.70	7.96	8.41	2.88	3.76	0.66	6.42	1.55	0.88	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	247.95	10.24	6.48	2.51	4.39	0.42	2.51	1.88	0.63	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	146.83	8.61	9.96	3.36	1.35	0.54	1.88	2.56	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	251.01	12.09	7.15	3.92	2.38	2.21	1.53	1.02	0.68	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	253.72	11.95	7.33	4.24	3.66	1.16	2.51	0.96	0.58	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	148.21	9.11	8.77	2.24	1.20	1.38	2.24	2.41	1.03	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	235.24	10.42	7.41	3.57	2.06	1.10	1.37	1.51	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	269.07	10.51	8.70	4.27	4.10	1.31	1.81	1.15	1.15	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	127.82	5.97	7.67	2.22	1.87	0.85	2.73	1.19	0.68	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	271.06	8.14	8.88	2.96	2.96	1.48	3.11	1.63	0.59	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	269.48	10.13	8.00	4.26	2.93	1.33	1.07	1.60	0.53	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	86.14	4.98	8.30	1.66	1.24	0.55	1.11	1.24	0.14	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	201.20	7.62	8.81	2.86	2.38	0.24	2.86	1.43	0.48	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	243.06	8.46	12.09	1.81	2.22	1.21	0.20	1.21	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	102.46	6.40	8.85	1.98	0.85	0.47	2.35	0.94	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	184.81	4.19	5.94	1.05	0.70	0.00	1.40	2.45	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	162.89	7.86	4.23	2.42	1.21	0.30	1.51	0.91	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	105.01	5.39	8.08	2.08	1.59	1.22	1.84	0.86	0.61	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	172.33	5.53	9.02	2.47	1.75	0.58	0.15	0.73	0.44	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	215.38	7.30	7.30	3.65	5.48	1.22	3.04	0.61	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	97.65	4.82	9.95	3.01	2.11	1.51	2.11	2.41	1.51	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	165.12	7.92	6.11	2.71	2.71	1.13	3.85	0.68	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	231.84	6.89	6.29	2.10	4.19	0.60	2.70	1.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	69.43	4.37	8.38	1.30	1.77	0.35	0.59	1.06	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	171.61	7.47	6.62	3.42	2.13	0.85	7.04	0.85	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	228.97	7.21	9.01	4.81	2.40	2.40	1.20	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	140.49	18.81	5.64	9.59	3.20	0.19	2.07	1.50	0.19	0.00
Schwann Cells, donor2	11578-120F3	180.33	17.01	3.40	10.21	3.40	0.00	3.40	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	136.49	6.13	4.38	9.42	0.88	0.66	2.63	1.10	0.66	0.00
Sebocyte, donor1	11220-116B5	209.80	5.48	9.31	3.29	0.55	0.00	0.00	0.55	0.55	0.55
Sebocyte, donor2	11301-117B5	200.83	6.89	2.30	2.76	0.92	0.46	0.46	0.00	0.46	0.46
Sebocyte, donor3	11378-118B1	169.01	8.04	4.95	1.65	2.27	0.21	0.62	0.41	0.00	0.21
Sertoli Cells, donor1	11255-116F4	129.21	13.25	6.63	4.97	6.63	1.66	0.00	4.97	3.31	1.66
Sertoli Cells, donor2	11333-117F1	84.73	2.82	2.82	0.00	0.00	5.65	2.82	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	219.68	9.85	6.07	2.73	2.73	0.53	0.18	0.79	0.44	0.26
Skeletal Muscle Cells, donor2	11358-117H8	80.96	7.95	3.61	1.45	2.89	0.00	1.45	2.17	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	194.80	13.38	8.36	15.05	5.85	0.84	4.18	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	121.75	7.85	8.33	4.71	2.04	1.10	1.73	0.94	0.31	0.31
Skeletal Muscle Cells, donor5	11455-119A6	121.44	7.88	4.76	2.68	2.38	0.45	1.64	1.93	0.30	0.15
Skeletal Muscle Cells, donor6	11459-119B1	159.90	10.31	9.54	6.16	2.92	0.31	2.46	2.15	0.31	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	166.71	6.30	4.03	2.39	1.89	0.38	1.01	1.39	0.38	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	151.39	8.99	5.14	2.28	2.57	0.71	0.71	1.00	0.57	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	215.58	12.40	7.54	5.95	2.58	0.89	2.48	1.69	0.30	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	158.14	7.41	4.04	2.02	3.54	1.77	0.42	1.77	0.51	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	215.68	14.48	3.62	7.96	0.72	0.72	4.34	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	80.77	6.60	4.54	3.85	3.16	1.79	1.51	1.79	0.41	0.14
Skin - palm, donor1	10286-104F7	139.68	5.37	2.69	5.37	8.06	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	127.00	4.61	2.88	0.86	1.59	0.58	0.86	1.44	0.14	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	94.88	1.64	5.73	0.82	0.82	2.45	0.00	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	151.12	7.92	2.99	1.30	1.82	0.13	0.39	0.65	0.39	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	182.66	5.42	4.17	1.53	2.50	1.11	1.25	1.11	1.25	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	159.22	7.74	4.08	1.41	1.83	1.27	1.55	1.69	0.56	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	150.97	4.86	5.07	1.90	0.63	2.11	0.00	0.63	0.63	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	131.46	6.30	3.60	2.10	2.92	0.37	1.20	0.97	0.07	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	44.44	3.09	2.47	1.23	0.62	0.93	0.93	2.16	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	15.12	0.89	2.22	0.00	0.67	1.78	0.22	0.67	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	146.37	8.82	2.35	5.88	5.88	1.18	0.00	0.59	1.76	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	230.49	9.06	8.62	3.09	2.43	1.10	0.66	0.88	0.88	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	110.26	4.73	4.33	1.97	1.58	0.39	0.00	1.97	0.79	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	143.70	6.95	3.86	3.09	2.32	0.77	0.00	1.55	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	76.06	5.00	1.00	1.00	1.00	0.00	0.00	0.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	198.29	10.51	3.46	2.79	1.86	1.20	0.13	1.73	1.46	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	98.41	5.76	2.88	3.77	2.22	0.66	1.11	1.77	0.22	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	71.18	6.02	2.05	3.07	3.20	1.92	0.38	2.30	1.28	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	60.89	5.54	3.58	3.58	1.30	0.65	0.33	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	50.80	3.25	3.25	2.07	1.18	0.30	0.30	0.59	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	58.65	2.42	2.70	1.00	2.14	0.14	0.43	0.71	0.43	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	123.96	8.30	5.53	3.58	3.42	0.49	0.00	0.81	0.49	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	71.24	2.74	3.65	2.44	0.61	0.30	0.91	1.22	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	121.99	8.33	5.81	4.04	3.03	0.51	0.51	2.53	1.52	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	208.10	6.12	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	142.10	8.58	3.34	2.86	2.38	0.95	1.43	2.38	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	73.15	4.13	1.77	1.62	1.18	0.29	0.44	0.74	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	80.28	4.09	1.51	0.22	0.43	0.86	1.29	0.00	0.00	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	102.23	7.56	2.73	3.15	2.73	0.21	1.05	0.63	0.10	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	146.33	9.13	4.18	4.02	3.25	1.55	0.15	1.70	2.01	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	118.57	6.47	3.23	2.16	2.16	1.08	0.00	0.00	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	115.06	10.16	1.79	3.29	2.99	1.49	0.60	2.09	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	201.08	14.34	10.58	5.12	1.71	0.68	0.34	1.02	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	131.77	7.07	3.69	1.88	1.57	0.79	1.02	1.02	0.31	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	100.74	5.54	1.71	1.51	1.61	0.40	0.40	1.61	0.70	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	188.64	7.96	4.32	1.82	2.05	0.68	1.14	1.59	0.46	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	100.23	8.45	0.60	1.21	3.62	1.81	2.42	1.81	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	243.73	14.31	8.48	7.95	2.65	0.53	2.12	1.06	0.53	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	59.79	9.45	3.06	3.86	1.60	1.07	0.40	0.67	0.40	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	77.89	4.63	3.51	2.13	1.63	0.50	1.25	1.25	0.25	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	38.05	1.78	1.52	0.76	1.01	0.25	0.00	1.01	0.76	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	99.96	7.09	3.47	4.98	2.71	0.15	0.30	1.21	0.75	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	90.77	1.50	3.00	3.75	5.25	2.25	0.75	0.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	376.03	11.63	42.64	14.21	2.58	1.29	0.00	3.88	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	142.78	6.98	7.44	1.40	2.79	1.40	0.00	0.93	0.93	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	175.19	8.08	2.02	3.03	1.01	1.01	2.52	4.04	1.01	2.52
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	110.31	10.03	2.82	2.19	1.25	0.31	0.63	1.88	0.94	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	65.19	4.42	2.36	1.77	3.83	0.88	0.00	2.06	0.29	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	152.62	13.41	6.83	7.83	2.25	0.67	0.33	1.17	0.08	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	116.32	5.61	2.80	0.47	3.74	0.47	0.00	1.40	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	164.79	8.92	4.61	3.31	3.02	1.15	0.72	1.73	1.15	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	223.09	13.00	4.84	4.84	3.06	0.51	2.55	3.06	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	111.88	11.09	4.14	4.89	3.01	0.38	1.50	1.69	0.38	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	127.03	6.57	5.87	4.33	2.52	0.28	0.56	1.82	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	84.12	4.61	5.03	1.51	2.60	0.42	0.08	0.67	0.17	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	167.62	11.43	2.38	1.43	3.33	0.48	0.48	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	138.23	6.85	1.71	1.22	3.43	0.24	0.24	3.67	0.98	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	35.57	1.33	2.43	0.88	3.09	0.22	0.22	0.66	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	93.63	4.68	4.10	5.85	2.93	0.29	0.59	1.46	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	82.60	3.30	1.55	0.78	0.19	0.00	0.19	0.19	0.39	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	77.48	2.12	1.59	0.53	0.00	0.26	0.00	0.26	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	65.83	1.12	1.49	0.37	0.74	1.12	0.00	0.00	0.74	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	80.49	4.67	1.08	1.44	1.08	0.72	0.72	1.08	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	56.50	3.12	1.70	0.57	0.28	0.00	0.28	0.57	1.14	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	209.54	8.67	2.76	5.91	1.58	0.79	0.79	1.18	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	99.55	2.03	4.06	0.51	1.27	0.25	0.76	0.25	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	82.26	3.99	2.00	0.00	0.00	0.00	0.00	0.40	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	104.08	4.18	3.34	0.00	0.42	0.42	0.42	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	103.13	6.42	0.92	3.21	1.38	0.00	0.92	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	101.50	4.04	2.36	2.19	2.02	0.17	0.17	0.00	1.18	0.17
Synoviocyte, donor2	11368-117I9	113.65	4.53	2.85	1.68	4.19	0.34	2.01	1.51	1.68	0.67
Synoviocyte, donor3	11440-118H9	58.53	4.24	2.68	2.23	1.56	0.67	0.89	1.56	1.34	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	249.42	17.87	11.43	7.86	2.86	1.79	0.00	1.79	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	172.44	13.87	7.93	0.00	1.98	0.00	1.98	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	198.67	13.89	5.33	4.63	3.24	0.69	1.85	2.32	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	366.31	12.40	10.54	3.87	2.44	1.65	0.65	1.51	0.57	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	194.44	7.73	5.03	1.93	3.09	1.16	2.71	0.77	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	196.42	10.88	6.30	5.15	2.29	0.57	1.72	0.57	1.72	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	144.92	6.40	6.77	1.60	2.71	0.37	0.49	0.37	0.37	0.25
Urethra, donor2	10319-105A4	59.35	5.40	7.19	1.80	1.80	1.80	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	169.76	7.97	10.63	2.13	1.59	0.53	0.00	0.80	1.33	0.27
Urothelial Cells, donor2	11600-120H7	213.90	8.01	3.61	2.40	3.20	0.00	1.60	1.60	0.00	0.80
Urothelial Cells, donor3	11681-122H7	180.16	7.79	7.11	1.60	3.44	0.46	1.60	0.92	0.23	0.00
Urothelial cells, donor0	11216-116B1	178.76	8.25	4.68	2.23	4.46	0.67	0.45	0.22	1.11	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	258.93	20.47	9.79	3.56	0.00	0.89	7.12	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	303.08	22.87	12.87	4.29	1.43	1.43	7.15	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	279.97	15.74	4.11	3.42	3.42	0.00	7.53	0.00	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	191.80	8.95	5.85	2.07	0.69	0.34	0.34	0.34	0.69	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	191.16	8.13	2.91	1.74	1.16	0.58	2.32	1.16	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	159.31	5.21	6.25	1.04	1.04	0.00	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	249.64	13.77	7.34	0.92	1.84	0.92	0.92	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	349.64	16.43	4.56	2.74	1.83	0.91	10.04	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	195.03	17.02	5.43	8.14	3.95	4.32	2.10	1.36	0.00	1.36
Wilms' tumor cell line:HFWT	10597-108E3	290.41	29.04	3.52	7.92	4.40	2.64	0.88	3.52	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	286.02	21.51	7.26	13.13	3.35	0.00	1.68	0.84	0.00	0.00
achilles tendon, donor2	10292-104G4	97.13	4.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	449.74	29.83	15.04	14.02	3.31	9.18	0.51	0.76	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	550.25	27.40	14.39	4.41	1.16	79.64	1.39	1.39	0.46	12.54
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	251.42	34.43	10.57	12.94	1.66	0.83	0.47	0.71	0.24	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	314.02	17.96	12.25	6.80	1.36	8.71	1.09	0.27	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	455.64	24.45	9.84	4.22	1.69	0.84	3.65	1.97	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	399.28	15.86	11.84	2.75	1.48	0.63	1.27	5.50	1.27	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	362.31	13.88	4.90	4.08	1.63	1.36	2.45	3.27	1.63	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	415.52	14.98	5.73	2.64	0.44	0.00	3.08	3.97	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	378.55	13.88	5.72	4.49	2.04	0.00	5.31	2.04	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	373.15	18.25	8.54	3.11	1.16	0.78	2.72	1.55	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	367.45	14.90	10.49	3.50	1.84	0.74	5.15	1.66	0.37	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	218.43	11.70	15.60	0.00	0.00	3.90	7.80	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	218.21	12.55	6.97	2.56	1.86	1.63	2.09	1.39	0.70	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	316.64	17.35	7.25	2.59	1.81	1.04	3.62	0.78	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	313.29	15.78	5.84	2.92	0.58	0.29	2.63	1.46	0.29	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	186.83	12.55	5.11	2.32	1.86	0.46	0.93	0.93	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	324.48	10.69	8.64	0.41	1.65	0.00	2.47	2.88	1.65	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	279.94	19.34	8.29	6.45	1.53	1.53	0.00	4.30	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	347.77	20.48	13.23	7.68	2.13	2.56	1.71	3.84	1.28	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	274.78	14.25	10.92	7.89	1.52	1.82	0.91	3.94	2.73	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	343.73	17.09	13.48	8.67	2.41	0.24	0.48	3.13	2.41	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	470.87	20.71	10.69	2.45	0.67	2.00	4.68	2.00	1.11	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	155.10	7.34	4.00	2.00	1.00	0.67	0.00	0.33	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	535.16	22.30	13.01	14.87	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	311.87	14.31	9.42	3.39	1.88	0.00	3.01	1.88	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	342.36	12.21	6.54	0.87	1.31	0.44	0.44	2.62	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	352.40	35.61	9.37	9.37	3.75	3.75	0.00	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	130.94	8.24	8.48	5.65	6.83	1.65	0.24	1.41	0.47	0.24
adipose tissue, adult, pool1	10010-101C1	61.43	1.40	5.89	0.31	1.24	0.00	0.47	0.62	0.31	0.16
adipose, donor1	10184-103D4	633.91	11.14	17.59	8.80	9.97	4.10	7.04	2.35	0.00	0.59
adipose, donor2	10185-103D5	148.01	12.98	5.68	12.17	8.11	4.06	0.81	0.00	0.00	0.00
adipose, donor3	10186-103D6	183.79	11.44	7.90	7.08	11.98	2.45	1.09	1.09	0.27	0.00
adipose, donor4	10187-103D7	298.16	13.00	8.67	6.07	19.94	6.07	4.33	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	77.81	8.21	7.89	8.36	3.95	1.26	0.95	2.21	0.63	0.32
adrenal gland, adult, pool1	10081-102A9	36.38	3.64	3.64	3.64	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	214.12	10.67	9.21	4.27	4.40	0.13	0.27	0.80	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	451.63	26.80	5.36	8.58	1.79	0.36	2.50	1.43	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	199.62	8.58	9.51	1.62	6.03	0.46	1.62	0.93	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	174.80	11.16	8.79	3.72	5.07	1.01	0.68	0.34	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	125.50	10.61	7.95	0.88	7.66	0.00	1.47	0.59	0.29	0.00
amygdala - adult, donor10196	10167-103B5	13.04	3.56	3.56	2.37	0.00	1.19	2.37	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	35.08	2.43	3.85	2.03	8.31	1.01	1.42	0.81	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	46.48	2.58	0.97	1.29	2.26	1.29	0.00	0.97	0.00	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	108.10	4.46	5.22	0.38	3.95	0.51	0.25	2.42	0.76	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	449.63	28.24	14.12	4.19	3.31	4.41	2.65	2.65	0.22	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	312.32	31.07	7.35	8.68	8.35	8.02	3.01	1.67	0.67	1.00
aorta, adult, pool1	10052-101G7	58.64	4.31	6.08	1.77	4.90	0.78	2.35	2.35	0.78	0.00
appendix, adult	10189-103D9	79.18	6.21	5.05	2.33	1.55	0.78	1.16	1.16	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	178.16	10.66	4.47	2.75	6.88	4.82	1.03	16.85	3.78	0.34
artery, adult	10190-103E1	44.84	0.00	2.72	5.43	8.15	1.36	4.08	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	218.75	14.20	9.27	6.37	4.64	2.32	1.16	2.17	0.29	0.87
b cell line:RPMI1788	10427-106D4	127.14	6.84	7.44	1.49	2.38	1.34	0.74	1.04	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	85.45	3.33	2.50	1.94	2.50	1.11	0.55	1.39	0.00	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	211.36	11.91	6.15	6.65	2.28	1.09	0.50	5.06	0.79	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	313.16	11.72	9.88	3.18	4.85	0.84	0.33	0.67	0.17	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	149.32	4.47	4.47	2.24	1.68	0.00	1.12	1.12	0.00	0.56
bladder, adult, pool1	10011-101C2	68.12	2.28	5.65	1.41	3.59	0.22	0.43	0.22	0.22	0.00
blood, adult, pool1	10053-101G8	281.26	22.15	6.64	4.43	0.00	2.21	4.43	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	161.85	6.85	2.57	4.28	2.57	0.00	0.00	1.71	0.00	0.00
bone marrow, adult	10192-103E3	79.63	2.70	1.35	1.35	1.35	0.00	1.35	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	35.88	3.08	3.08	3.08	9.23	3.08	3.08	1.03	1.03	1.03
brain, adult, pool1	10012-101C3	29.51	2.00	2.56	1.56	7.02	0.45	0.56	1.00	0.56	0.22
brain, fetal, pool1	10085-102B4	64.11	5.34	2.67	2.67	5.34	2.67	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	368.03	27.75	11.56	15.53	5.95	2.97	2.64	1.98	1.65	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	284.97	12.36	8.74	6.99	8.74	3.25	0.25	0.37	0.87	1.25
breast, adult, donor1	10080-102A8	97.86	2.53	4.42	1.26	3.16	0.63	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	236.04	42.94	8.64	20.45	7.50	2.16	6.48	0.38	0.51	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	372.92	17.32	15.15	7.11	8.35	2.47	1.24	1.24	0.00	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	142.28	3.68	11.28	3.68	0.46	0.69	3.45	0.46	0.00	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	416.39	26.39	12.10	15.74	8.96	0.48	3.63	0.48	0.24	0.48
carcinoid cell line:NCI-H1770	10703-109H1	137.76	6.11	10.34	1.41	3.29	1.41	0.94	0.00	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	163.85	14.66	5.36	5.91	3.83	2.08	0.66	0.88	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	177.46	13.63	6.34	6.34	1.90	0.00	1.90	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	149.06	12.24	6.12	9.85	4.79	0.27	3.73	0.00	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	34.54	1.15	3.45	4.61	4.61	1.15	1.15	4.61	1.15	2.30
caudate nucleus, adult, donor10252	10164-103B2	38.15	3.18	4.02	2.51	6.86	0.67	0.84	2.34	1.51	0.50
caudate nucleus, adult, donor10258	10379-105H1	22.16	3.82	1.53	3.82	5.35	0.76	0.00	1.53	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	75.08	4.03	2.20	0.73	4.03	2.56	0.37	1.46	2.56	1.46
cerebellum - adult, donor10196	10173-103C2	46.61	5.83	5.83	2.91	2.91	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	56.37	2.14	7.47	1.49	8.11	1.28	0.64	0.00	0.00	0.43
cerebellum, adult, pool1	10083-102B2	31.39	3.45	8.97	3.79	9.66	0.34	1.72	0.69	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	108.77	7.47	5.81	1.66	2.49	4.98	0.83	4.15	0.83	0.83
cerebral meninges, adult	10188-103D8	25.72	1.26	2.27	2.77	5.55	0.25	0.25	0.76	1.01	1.01
cerebrospinal fluid, donor2	10294-104G6	69.43	2.92	2.19	1.46	2.19	1.46	1.46	1.46	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	306.54	14.09	16.97	3.02	13.37	2.73	0.58	1.01	1.15	0.72
cervical cancer cell line:ME-180	10553-107I4	154.28	6.13	5.63	1.99	2.98	3.15	0.33	1.16	0.50	0.99
cervix, adult, pool1	10013-101C4	88.30	3.46	6.30	1.78	3.15	0.31	0.42	0.94	0.31	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	225.31	8.22	5.99	0.84	0.84	0.84	0.84	0.70	0.56	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	84.91	5.23	2.61	1.31	1.31	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	219.10	8.33	10.81	2.86	2.11	2.73	0.62	3.36	2.11	0.50
choriocarcinoma cell line:SCH	10785-110H2	247.41	11.46	11.71	2.22	4.07	1.11	1.60	2.22	0.49	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	52.65	2.85	6.64	1.19	1.66	1.42	0.47	1.42	1.42	0.00
chorionic membrane cells, donor1	12238-129G6	128.21	5.41	7.41	0.85	3.42	0.28	1.42	0.00	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	134.63	7.66	8.75	3.88	2.78	1.09	0.80	0.50	0.10	0.20
chorionic membrane cells, donor3	12240-129G8	78.03	3.30	10.44	0.00	4.40	1.10	2.20	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	211.05	19.19	8.08	9.09	1.01	3.03	3.03	1.01	2.02	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	412.05	26.32	8.84	9.03	3.07	0.58	2.88	1.92	0.38	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	327.97	19.01	6.97	9.71	4.01	0.42	0.84	1.27	0.42	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	310.47	13.61	9.24	5.14	1.03	0.26	1.28	0.51	0.26	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	323.87	13.55	7.74	2.90	1.69	2.18	1.69	0.48	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	305.41	7.13	5.70	3.66	1.63	2.44	0.81	0.41	0.41	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	500.28	26.21	11.48	8.83	2.65	4.12	0.88	0.29	0.29	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	399.54	11.47	10.16	2.87	0.78	0.26	0.26	0.52	0.52	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	187.44	7.54	14.17	4.34	5.49	2.51	4.11	1.60	0.23	0.69
clear cell carcinoma cell line:TEN	10636-108I6	335.56	13.53	6.07	6.07	3.12	3.30	2.26	0.69	1.04	0.52
colon carcinoma cell line:CACO-2	10513-107D9	294.70	24.53	6.59	7.87	4.94	6.04	0.18	0.92	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	324.21	13.68	14.82	2.28	2.66	3.04	1.14	0.38	0.38	0.00
colon, adult, donor1	10082-102B1	161.84	9.52	9.52	11.90	8.33	1.19	2.38	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	163.56	7.40	9.28	2.12	3.76	0.71	0.12	0.94	0.00	0.24
colon, fetal, donor1	10070-101I7	84.66	3.71	2.47	5.56	3.09	2.47	0.00	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	421.68	27.50	22.92	4.58	0.00	4.58	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	150.22	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	86.26	6.80	0.42	0.85	2.55	0.85	0.42	0.85	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	147.91	7.85	4.68	3.32	2.11	0.91	0.30	1.21	0.30	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	162.16	11.28	4.37	3.24	1.55	0.85	0.56	2.12	0.28	0.42
corpus callosum, adult, pool1	10042-101F6	59.26	2.99	9.07	3.43	6.19	0.33	0.66	1.66	4.09	0.44
cruciate ligament, donor2	10295-104G7	98.88	0.81	2.43	3.24	3.24	0.00	2.43	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	65.81	2.41	4.82	0.80	8.03	0.80	0.00	0.00	2.41	0.00
diencephalon, adult	10193-103E4	25.44	1.92	2.64	1.92	2.16	0.72	0.72	0.48	0.96	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	380.92	19.98	18.60	8.04	3.67	12.17	9.87	4.59	0.92	1.61
ductal cell carcinoma cell line:KLM-1	10438-106E6	210.02	8.72	7.69	3.33	5.13	1.54	0.77	0.77	0.26	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	221.46	10.11	5.06	2.89	2.41	0.72	0.72	1.44	0.48	0.00
ductus deferens, adult	10196-103E7	59.80	1.00	1.99	1.00	3.99	1.00	1.50	0.50	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	92.17	1.44	2.88	2.88	1.44	2.88	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	100.78	6.62	2.21	1.47	2.21	2.21	1.47	1.47	0.00	0.00
dura mater, adult, donor1	10041-101F5	107.78	5.62	5.62	3.06	3.63	0.25	0.41	0.66	0.74	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	159.00	7.33	2.22	2.22	4.89	2.00	0.00	3.78	0.44	1.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	167.65	12.75	4.30	4.73	4.16	5.16	0.86	1.15	0.29	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	233.08	9.87	10.48	3.08	1.85	0.00	0.00	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	132.28	5.45	3.94	1.21	1.51	0.30	0.61	2.12	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	205.01	9.57	9.57	1.23	4.01	0.93	0.31	1.23	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	221.98	15.76	7.88	1.31	3.94	0.00	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	405.92	26.15	11.06	4.36	5.03	4.02	1.34	1.34	1.01	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	149.16	4.89	11.24	3.44	4.53	1.63	0.72	1.81	0.91	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	105.33	4.02	3.86	1.29	0.96	2.25	2.25	1.45	0.96	0.64
epidermoid carcinoma cell line:A431	10426-106D3	377.38	13.01	10.23	5.00	3.11	0.89	0.89	0.56	0.56	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	322.81	13.75	10.67	4.51	3.52	1.54	0.55	1.76	0.99	0.66
epididymis, adult	10197-103E8	47.30	1.88	3.56	1.47	5.44	2.51	0.84	1.47	1.88	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	187.88	11.53	6.74	4.44	0.89	0.35	0.00	0.35	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	117.19	9.04	1.57	3.93	1.18	0.00	0.39	0.79	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	417.79	19.92	17.56	9.30	7.08	4.98	9.57	7.73	1.44	1.83
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	357.26	16.34	15.94	5.31	5.31	4.53	6.79	4.63	1.48	1.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	457.42	20.95	16.24	9.52	7.39	3.70	9.07	6.16	1.23	2.02
esophagus, adult, pool1	10015-101C6	121.47	4.88	7.11	1.17	2.65	0.85	0.74	0.11	0.32	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	107.08	8.14	2.88	3.63	3.63	2.50	0.13	0.25	0.00	0.38
eye - muscle inferior rectus, donor1	10272-104E2	74.85	4.83	4.83	4.83	0.00	0.00	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	46.29	2.10	12.63	0.00	2.10	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	47.62	5.95	0.00	0.00	7.44	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	68.79	3.44	0.00	3.44	3.44	0.00	1.15	0.00	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	65.58	2.91	1.46	0.00	2.91	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	57.20	4.07	3.56	1.78	7.37	0.76	1.78	0.76	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	226.44	10.13	8.85	5.90	2.31	0.77	0.77	0.90	0.00	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	244.78	17.81	5.46	3.80	2.85	0.00	0.95	1.90	0.47	0.24
frontal lobe, adult, pool1	10040-101F4	22.61	1.88	4.22	1.97	5.82	0.84	0.00	0.47	0.28	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	705.29	32.13	19.22	9.61	7.81	3.30	1.20	0.60	0.60	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	390.34	9.88	8.32	2.56	2.19	0.27	0.37	0.09	0.00	0.09
gall bladder, adult	10198-103E9	88.85	4.10	2.66	1.93	5.07	0.00	1.21	1.21	2.66	0.00
gamma delta positive T cells, donor1	11937-126A2	69.79	3.22	6.98	0.54	0.00	0.54	0.00	1.07	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	58.26	2.99	5.23	0.75	0.37	0.37	2.24	0.75	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	341.11	13.52	5.91	4.65	3.80	1.27	4.22	0.21	0.63	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	196.70	13.93	5.80	3.48	3.29	0.97	1.74	0.39	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	120.51	7.54	11.64	2.46	1.80	2.95	0.16	1.15	0.00	0.49
gastric cancer cell line:GSS	10560-108A2	159.25	1.83	8.24	2.75	2.75	0.92	1.83	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	285.80	11.65	10.28	4.80	6.40	1.83	6.17	2.74	0.23	0.00
giant cell carcinoma cell line:LU65	10487-107B1	115.31	4.02	5.05	1.03	2.41	1.49	0.69	0.80	0.57	0.92
giant cell carcinoma cell line:Lu99B	10433-106E1	246.05	7.28	6.02	1.82	3.08	0.14	0.56	0.56	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	284.59	11.97	12.97	2.74	4.49	0.75	0.75	0.75	0.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	172.68	8.76	6.76	3.48	2.22	1.58	0.11	0.84	0.32	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	185.38	13.34	6.32	4.63	2.53	1.54	0.70	0.70	0.14	0.56
glioblastoma cell line:T98G	10485-107A8	228.91	16.11	7.17	7.51	1.88	1.21	0.55	0.88	0.33	0.00
glioma cell line:GI-1	10413-106B8	167.82	5.27	5.27	2.34	1.76	0.59	0.29	0.29	0.29	1.17
globus pallidus - adult, donor10196	10175-103C4	46.65	0.73	4.37	2.92	9.48	0.00	0.73	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	64.93	4.39	7.32	2.44	12.20	0.24	0.73	0.73	0.49	0.73
globus pallidus, adult, donor10258	10367-105F7	16.43	2.74	2.74	4.11	6.85	0.00	0.00	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	87.40	3.73	1.07	0.53	4.80	0.00	1.07	2.13	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	702.33	46.50	17.13	12.24	0.00	0.00	0.00	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	404.35	10.93	0.00	10.93	0.00	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	303.14	0.00	5.23	0.00	0.00	0.00	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	111.36	4.16	1.92	1.92	2.88	1.92	0.32	1.92	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	193.75	15.15	10.10	3.21	0.46	4.59	0.46	6.89	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	139.92	7.77	6.40	3.20	0.00	5.94	1.83	4.12	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	148.79	14.17	6.44	3.22	0.64	5.15	0.00	6.44	0.00	0.64
hIPS, biol_rep1	14380-156B6	204.09	5.75	10.06	4.31	0.00	10.06	1.44	10.06	0.00	2.87
hIPS, biol_rep2	14381-156B7	120.71	13.03	11.66	8.23	0.69	6.86	1.37	7.54	0.00	0.69
hIPS, biol_rep3	14382-156B8	37.52	1.10	2.21	0.00	3.31	3.31	0.00	2.21	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	111.78	9.48	6.32	3.74	2.59	0.29	1.15	1.15	0.86	0.00
heart - mitral valve, adult	10205-103F7	50.53	3.89	3.89	0.60	2.69	0.30	0.30	0.00	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	43.40	1.05	4.45	0.52	3.92	0.26	1.05	0.26	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	154.04	9.16	3.33	0.00	6.66	0.00	0.00	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	89.17	4.90	5.92	4.49	5.92	0.41	2.45	1.02	0.20	0.00
heart, adult, diseased, donor1	10051-101G6	68.98	1.28	6.81	1.28	10.22	0.85	2.98	0.00	0.00	0.43
heart, adult, pool1	10016-101C7	88.31	2.30	8.51	1.61	7.36	0.23	0.00	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	89.33	6.16	7.19	1.64	5.85	0.51	0.41	0.31	0.10	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	53.37	3.70	3.09	0.62	2.78	0.62	0.00	0.31	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	423.35	30.92	1.19	17.84	1.19	9.51	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	258.67	15.36	5.64	8.07	2.98	2.54	3.87	0.88	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	251.61	14.20	4.49	7.77	5.10	2.55	2.91	0.61	0.12	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	254.55	13.95	4.14	6.67	4.45	3.03	3.54	1.01	0.10	0.20
hepatoma cell line:Li-7	10484-107A7	351.00	14.79	8.23	2.34	1.78	1.33	1.11	2.11	0.33	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	226.93	11.16	9.75	3.02	2.61	2.31	1.11	2.11	0.60	0.50
hippocampus - adult, donor10196	10169-103B7	27.44	2.84	1.89	1.89	4.73	0.00	0.00	0.00	1.89	0.95
hippocampus, adult, donor10252	10153-102I9	52.66	2.86	5.51	1.22	9.59	0.61	1.43	1.22	1.22	0.82
hippocampus, adult, donor10258	10374-105G5	10.46	1.00	1.99	1.49	1.00	1.49	0.00	0.00	0.50	1.00
hippocampus, newborn, donor10223	10363-105F3	48.64	4.58	1.76	1.41	2.11	2.82	0.00	1.76	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	496.82	17.70	14.04	3.05	0.00	18.31	3.05	7.32	1.22	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	255.85	16.69	6.09	6.48	3.93	7.85	2.55	1.77	0.98	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	325.24	18.79	8.12	4.57	1.52	10.16	1.27	4.32	1.52	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	358.05	12.41	10.71	10.71	1.69	1.69	1.13	2.26	0.00	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	399.19	21.43	11.10	7.23	4.39	1.03	6.97	2.32	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	365.94	16.70	7.21	6.83	2.66	2.66	2.66	2.66	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	254.58	21.90	4.96	9.34	7.30	1.17	1.75	0.58	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	197.12	22.19	6.89	9.26	3.66	1.08	2.59	0.65	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	197.69	27.11	5.42	5.42	4.17	3.34	0.42	0.83	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	138.52	13.26	5.21	8.05	5.45	1.66	1.42	0.47	1.18	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	184.82	20.73	6.11	9.80	6.91	1.93	2.57	1.45	0.48	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	151.49	14.14	4.04	4.71	6.06	2.02	0.00	2.69	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	220.96	17.68	5.48	6.57	1.56	6.26	3.13	2.97	0.00	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	258.91	14.25	9.33	5.90	0.98	8.35	7.37	3.44	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	389.25	12.22	6.11	4.36	0.00	15.71	3.49	9.60	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	436.61	29.40	11.65	7.25	3.63	2.29	2.86	1.15	0.19	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	370.66	23.98	14.83	6.98	5.67	1.31	2.18	1.31	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	666.68	20.99	16.49	3.50	4.50	5.50	4.00	1.50	0.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	141.48	13.38	5.09	6.59	8.29	2.45	1.32	0.19	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	123.68	15.01	9.09	3.64	4.55	1.36	2.27	0.45	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	151.92	12.84	4.70	5.33	8.46	2.19	1.25	0.63	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	106.15	9.96	4.08	5.88	6.53	2.12	1.96	1.80	0.33	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	95.22	5.52	5.52	4.94	4.94	2.32	0.87	0.29	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	142.59	11.66	5.38	6.88	8.97	2.09	0.60	2.99	0.90	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	285.43	20.69	5.73	4.43	1.11	8.31	3.69	2.59	0.18	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	234.79	18.83	6.56	5.99	2.28	6.28	2.00	3.71	0.57	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	465.07	12.25	8.98	11.43	0.82	15.92	3.27	5.72	0.00	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	290.82	19.36	8.80	7.75	1.76	1.76	3.52	2.11	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	281.90	15.20	10.14	3.17	0.63	2.85	1.58	1.58	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	351.65	17.85	5.75	4.54	1.82	2.12	1.21	1.21	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	83.26	10.34	5.17	3.62	4.65	0.52	2.07	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	91.65	9.96	5.98	5.98	3.32	2.66	0.66	2.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	127.24	9.24	3.59	4.10	6.41	1.03	1.03	0.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	95.61	9.20	4.60	3.83	4.35	1.53	2.56	1.53	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	104.50	8.33	2.27	8.33	8.33	0.76	1.51	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	130.39	10.08	3.02	4.03	5.38	1.68	0.67	1.34	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	243.44	16.18	7.73	5.07	1.21	9.42	1.45	3.62	0.00	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	364.55	13.82	5.35	4.46	0.89	7.58	2.23	3.12	0.00	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	332.69	22.44	5.85	7.32	1.46	7.32	3.41	1.46	0.49	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	309.90	17.11	8.86	3.67	3.36	1.53	1.83	0.92	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	829.58	19.52	29.28	9.76	3.25	13.01	19.52	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	424.93	21.51	9.93	6.62	3.31	1.65	4.96	2.32	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	155.98	18.06	4.93	10.40	3.28	1.64	0.55	1.09	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	184.92	14.48	7.96	8.32	2.90	0.72	1.09	0.36	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	165.12	19.93	4.27	4.98	3.91	1.42	1.42	0.36	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	143.21	16.71	3.58	2.39	13.13	0.00	0.00	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	146.53	15.44	8.67	7.99	6.36	1.76	1.08	1.08	0.41	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	185.61	13.74	4.58	5.12	5.93	2.16	1.35	0.54	0.00	0.27
immature langerhans cells, donor1	11904-125F5	124.71	4.12	6.54	0.48	0.73	0.24	0.24	1.21	0.24	0.00
immature langerhans cells, donor2	11905-125F6	73.67	0.00	3.17	0.00	0.79	0.79	3.17	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	26.02	1.89	3.97	3.03	5.49	1.42	0.19	0.76	0.95	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	221.75	19.51	4.88	8.13	6.18	0.65	0.98	0.65	0.33	0.33
kidney, adult, pool1	10017-101C8	168.41	4.61	6.91	1.20	3.90	2.70	0.80	0.60	0.60	0.40
kidney, fetal, pool1	10045-101F9	136.31	7.29	7.85	2.76	4.74	3.61	0.28	0.85	0.28	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	330.62	28.12	10.51	2.84	4.69	0.71	0.14	1.42	0.00	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	98.01	5.67	5.39	2.07	5.11	1.66	3.04	1.38	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	128.63	7.16	5.69	3.30	5.14	1.65	0.55	1.28	0.55	1.47
left atrium, adult, donor1	10079-102A7	54.49	2.18	1.09	0.54	3.81	0.00	0.54	0.54	0.00	0.00
left ventricle, adult, donor1	10078-102A6	60.68	3.54	4.05	1.52	3.03	0.00	0.00	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	290.30	16.14	6.29	7.93	3.01	0.00	1.37	0.55	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	43.47	2.87	2.16	1.44	1.44	0.36	1.08	1.44	1.44	0.00
leiomyoma cell line:15242A	10570-108B3	27.72	1.63	1.63	1.63	1.63	0.00	1.09	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	63.62	2.67	0.73	1.94	2.43	0.73	1.94	0.24	0.49	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	0.00	0.00	12.70	6.35	0.00	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	100.37	11.50	0.00	2.09	2.09	1.05	0.00	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	255.01	7.32	5.78	0.94	0.94	0.47	1.77	0.59	0.12	0.24
liposarcoma cell line:KMLS-1	10782-110G8	57.17	3.75	2.66	3.12	2.81	2.50	1.25	0.47	0.62	0.16
liposarcoma cell line:SW 872	10726-110A6	132.20	10.60	5.97	4.39	3.17	0.49	0.85	0.73	0.24	0.24
liver, adult, pool1	10018-101C9	192.37	3.89	3.89	0.97	2.27	1.13	0.97	0.49	0.00	0.00
liver, fetal, pool1	10086-102B5	206.02	9.41	3.76	5.64	5.64	2.82	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	37.62	2.77	1.46	1.90	4.81	0.58	0.00	1.02	0.87	0.29
locus coeruleus, adult, donor10252	10165-103B3	45.21	1.29	7.01	0.74	8.67	0.37	0.74	1.48	0.74	0.18
locus coeruleus, adult, donor10258	10375-105G6	21.44	1.13	1.13	0.28	5.64	0.28	1.13	1.13	0.56	0.28
locus coeruleus, newborn, donor10223	10362-105F2	108.94	2.10	2.52	0.84	0.84	2.10	0.42	3.36	1.68	0.42
lung adenocarcinoma cell line:A549	10499-107C4	121.65	6.23	5.40	2.49	1.94	0.00	0.42	0.97	0.28	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	301.96	12.41	3.45	6.89	2.76	0.00	0.00	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	247.42	14.24	9.49	14.50	4.35	0.26	1.32	0.13	0.40	0.00
lung, adult, pool1	10019-101D1	116.00	4.37	5.55	2.01	1.54	0.35	1.06	1.65	1.30	0.12
lung, fetal, donor1	10068-101I5	114.45	6.56	7.99	2.85	4.57	2.00	0.29	7.14	3.71	0.86
lung, right lower lobe, adult, donor1	10075-102A3	60.94	5.04	5.04	1.37	3.21	0.00	1.83	2.75	1.37	0.00
lymph node, adult, donor1	10077-102A5	61.54	3.79	4.73	0.95	1.89	0.47	2.37	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	243.07	11.84	10.52	6.14	6.36	1.53	0.22	1.32	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	136.44	6.94	8.45	3.17	2.41	5.13	0.91	1.51	0.30	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	434.09	10.19	5.95	1.70	3.40	0.00	0.85	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	102.56	0.89	5.33	1.33	4.44	0.00	0.89	0.00	0.89	0.89
mature adipocyte, donor2	12232-129F9	75.13	1.25	4.57	1.25	2.08	0.62	0.21	0.21	0.21	0.00
mature adipocyte, donor3	12233-129G1	75.15	1.19	6.87	0.95	5.22	0.00	0.47	0.24	0.95	0.47
mature adipocyte, donor4	12234-129G2	77.39	2.37	5.26	1.05	1.84	0.26	0.26	0.53	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	233.02	9.53	10.48	4.29	8.82	4.77	0.00	0.24	0.48	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	18.05	3.38	3.38	4.51	1.13	1.13	4.51	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	42.11	1.10	3.68	2.21	8.28	0.92	1.47	0.55	1.29	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	21.29	1.27	2.54	1.59	2.54	0.32	0.32	0.95	0.64	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	53.31	1.28	2.99	0.00	1.28	0.43	1.28	2.99	0.85	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	39.49	1.86	1.86	2.53	6.58	1.18	1.35	1.52	0.00	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	50.72	2.33	5.73	1.49	7.43	1.27	0.42	0.42	0.21	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	0.00	1.93	3.85	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	28.71	1.08	2.87	0.72	1.08	1.79	0.36	1.44	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	64.25	3.89	2.60	3.24	2.60	1.30	1.30	6.49	3.24	0.65
medulla oblongata, adult, donor10252	10155-103A2	56.04	1.86	6.35	1.24	7.89	1.08	1.24	1.70	1.70	1.08
medulla oblongata, adult, pool1	10038-101F2	32.32	3.43	3.75	2.04	4.98	0.41	0.24	1.22	2.94	0.16
medulla oblongata, newborn, donor10223	10361-105F1	104.50	2.78	2.08	2.43	4.86	1.39	0.69	4.51	8.33	3.12
medulloblastoma cell line:D283 Med	10838-111E1	492.42	13.28	14.17	1.99	3.76	2.66	7.97	1.77	0.22	0.66
medulloblastoma cell line:ONS-76	10759-110E3	376.84	29.10	7.09	10.27	5.50	0.61	0.37	0.86	0.12	0.49
melanoma cell line:COLO 679	10514-107E1	91.14	5.89	4.74	2.59	3.45	0.43	0.14	0.29	0.00	0.14
melanoma cell line:G-361	10465-106H6	104.78	5.70	8.69	3.26	3.26	0.00	1.36	0.27	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	100.22	3.80	2.89	1.27	4.16	0.00	1.81	0.36	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	348.06	29.08	8.81	9.69	1.76	7.93	7.05	0.88	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	409.05	31.63	13.48	12.70	6.74	5.70	7.00	1.04	0.52	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	120.29	5.68	3.99	3.07	1.23	1.38	2.92	0.61	0.77	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	89.62	3.82	3.27	1.45	0.55	0.91	1.82	0.55	0.55	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	67.08	2.90	2.90	1.66	1.66	0.41	3.31	2.48	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	70.24	4.07	5.76	1.12	1.83	0.70	1.69	0.70	1.26	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	78.95	3.08	4.43	0.96	1.54	0.39	1.16	2.31	0.77	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	60.38	0.69	2.78	0.69	2.78	0.69	0.00	0.00	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	52.69	2.75	4.12	0.17	1.37	1.03	1.72	1.72	0.86	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	80.28	2.99	4.37	1.50	1.27	0.92	1.50	1.38	1.04	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	110.09	6.10	5.57	3.71	1.59	0.53	2.39	1.72	0.93	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	131.26	6.62	5.54	2.84	0.81	0.95	1.76	1.08	0.68	1.08
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	120.35	5.26	5.26	1.85	1.85	0.85	1.71	1.56	1.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	102.10	4.61	0.99	0.66	0.99	0.33	0.66	0.33	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	96.86	3.87	5.26	2.49	1.52	1.94	1.38	2.21	0.14	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	104.72	4.54	3.49	2.09	2.79	0.70	1.40	1.40	1.05	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	44.10	1.84	3.47	1.84	1.02	0.82	1.43	0.82	0.00	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	70.81	2.16	2.88	0.72	1.08	0.72	0.36	0.00	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	69.62	2.28	5.07	0.62	2.17	0.72	1.24	1.34	0.52	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	42.18	1.14	2.74	0.46	0.46	0.23	0.23	1.37	0.68	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	72.58	1.68	10.91	0.42	2.10	1.26	1.68	0.84	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	97.28	5.23	4.63	2.24	0.90	0.75	0.75	1.34	0.45	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	102.32	4.73	4.99	0.61	1.75	2.36	1.75	0.61	0.79	0.88
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	77.31	3.68	4.05	0.37	2.21	0.37	1.47	1.10	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	77.26	2.58	2.00	0.29	1.14	0.00	0.86	1.14	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	226.08	12.63	5.05	5.89	3.37	1.26	8.84	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	91.33	3.20	4.57	3.65	0.91	1.37	0.46	0.91	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	109.22	4.35	2.30	1.79	1.02	1.02	1.53	2.30	0.26	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	109.41	3.40	0.52	2.36	2.62	0.79	0.52	2.09	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	110.60	5.55	1.54	1.54	0.00	0.62	0.62	2.46	2.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	103.79	5.65	1.88	1.18	1.88	0.47	1.41	1.65	0.47	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	114.74	5.42	2.03	4.06	1.35	0.34	0.34	1.35	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	118.28	5.11	1.18	3.14	1.57	0.39	1.57	2.36	1.96	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	122.33	3.24	2.32	2.32	1.39	0.93	0.46	1.39	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	143.34	5.48	4.04	2.60	1.73	0.87	0.87	2.02	1.73	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	106.20	4.24	2.45	2.23	2.45	1.34	0.67	0.67	0.67	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	106.96	5.05	3.61	1.92	1.68	0.72	0.72	2.40	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	104.13	1.47	2.93	3.67	0.73	0.73	0.00	2.93	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	107.41	4.70	3.36	3.69	0.34	1.01	0.34	1.34	2.01	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	117.08	7.78	4.09	1.64	1.23	0.41	0.41	1.23	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	119.85	3.87	3.44	2.58	1.29	0.43	0.43	1.72	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	131.25	0.00	2.73	0.00	8.20	0.00	2.73	8.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	144.62	5.16	0.00	0.00	5.16	5.16	0.00	5.16	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	139.66	4.55	1.62	3.90	1.95	0.32	1.30	2.92	0.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	126.58	4.36	4.36	1.45	0.00	0.00	1.45	1.45	1.45	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	160.46	10.13	2.67	2.67	0.00	1.60	0.53	1.60	1.07	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	134.93	4.09	4.91	3.27	3.27	1.64	1.64	1.64	1.64	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	114.28	6.22	2.72	1.94	2.33	0.78	0.78	2.33	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	153.21	4.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	148.03	5.96	1.99	1.99	0.99	0.00	1.99	2.98	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	128.71	4.77	0.00	0.00	0.00	0.00	0.00	4.77	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	125.71	4.15	1.78	1.78	1.19	1.78	0.00	1.78	1.19	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	115.75	6.09	2.44	1.22	1.22	1.22	0.00	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	157.71	5.70	3.17	3.80	0.00	0.63	1.90	3.80	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	97.61	3.45	1.03	1.38	1.38	0.69	0.34	1.38	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	118.21	2.15	2.15	0.00	2.15	0.00	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	119.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	68.88	10.33	3.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	86.38	2.44	1.22	0.81	2.04	0.81	0.81	3.26	0.41	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	81.03	7.94	3.18	0.79	0.79	1.59	1.59	2.38	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	78.41	4.13	0.00	0.59	1.18	1.77	0.59	0.59	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	72.00	4.05	3.43	0.62	1.87	0.31	0.31	1.87	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	80.20	4.01	2.67	2.67	2.67	0.00	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	112.35	7.10	4.73	0.00	1.18	0.00	0.00	2.37	2.37	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	115.56	10.27	0.00	0.00	2.57	0.00	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	141.81	6.20	2.07	0.69	2.07	0.00	0.69	0.69	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	98.47	3.46	4.95	1.48	1.48	0.00	0.49	0.49	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	86.36	2.24	6.73	0.00	1.12	0.00	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	99.86	3.18	3.82	0.64	1.27	0.00	0.64	0.64	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	93.90	1.61	2.42	0.00	1.21	0.00	0.81	0.00	0.81	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	100.31	2.18	4.36	0.00	2.18	0.00	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	84.89	2.53	3.80	0.00	2.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	43.09	2.43	3.03	0.00	1.21	1.21	1.82	0.00	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	58.75	4.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	65.07	1.65	2.47	1.65	0.00	0.82	2.47	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	87.90	5.36	2.18	0.40	1.59	0.79	0.20	1.39	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	95.40	3.89	2.92	0.00	1.62	0.32	1.62	1.30	0.97	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	103.90	6.11	4.07	1.02	2.04	0.00	1.02	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	116.06	6.19	1.55	2.32	3.87	0.00	0.00	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	282.31	6.85	13.94	2.60	4.25	1.42	0.47	0.47	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	262.25	20.39	4.40	6.49	1.85	0.93	0.46	2.55	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	307.70	21.37	4.27	0.00	0.00	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	363.02	9.66	4.93	4.21	1.95	0.62	0.72	1.23	0.21	0.10
mesothelioma cell line:Mero-25	10850-111F4	411.92	15.43	5.22	4.09	3.63	1.36	3.18	5.67	0.68	0.45
mesothelioma cell line:Mero-41	10851-111F5	322.46	12.96	5.87	7.58	2.44	1.22	1.71	1.47	0.73	0.24
mesothelioma cell line:Mero-48a	10852-111F6	279.67	17.71	4.87	3.32	5.54	1.99	2.88	3.54	1.11	0.66
mesothelioma cell line:Mero-82	10853-111F7	269.11	14.72	4.99	2.63	2.37	1.05	2.63	2.10	0.00	0.79
mesothelioma cell line:Mero-83	10854-111F8	199.84	9.53	2.89	2.89	1.87	0.68	2.38	3.40	0.85	0.68
mesothelioma cell line:Mero-84	10855-111F9	228.25	12.13	4.55	3.79	2.53	1.52	2.02	4.04	0.25	0.51
mesothelioma cell line:Mero-95	10856-111G1	314.70	14.29	7.45	6.63	3.73	4.14	3.11	5.80	1.04	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	143.62	10.27	4.97	2.82	3.31	1.49	1.82	1.99	0.33	0.50
mesothelioma cell line:NCI-H226	10846-111E9	214.29	10.68	2.17	5.07	1.81	0.36	1.99	0.72	0.00	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	217.80	10.08	4.10	6.49	1.02	0.85	1.88	2.05	0.17	0.34
mesothelioma cell line:NCI-H28	10845-111E8	312.74	15.78	10.94	4.33	3.82	5.34	5.09	3.31	0.51	1.27
mesothelioma cell line:No36	10857-111G2	214.64	11.09	2.28	4.57	3.26	0.33	2.94	0.98	0.65	0.33
mesothelioma cell line:ONE58	10858-111G3	176.12	5.96	3.25	2.98	1.90	0.00	0.81	0.81	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	44.53	0.58	6.14	0.00	1.73	0.38	0.19	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	45.18	0.85	4.40	0.49	1.71	0.24	0.12	0.61	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	49.36	1.97	5.56	0.54	0.36	0.36	0.54	0.54	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	137.77	4.57	9.47	1.96	1.96	1.31	2.94	1.63	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	138.61	10.17	8.90	4.03	2.54	1.70	2.97	2.33	0.42	1.48
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	368.57	26.26	8.06	9.44	6.91	0.92	0.23	1.38	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	91.15	7.23	5.14	1.90	2.85	0.95	0.19	2.47	0.38	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	413.93	21.81	9.79	4.07	2.03	1.48	1.11	0.37	0.55	0.18
myeloma cell line:PCM6	10474-106I6	89.15	4.74	2.77	2.77	2.37	0.59	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	291.18	18.77	12.17	7.61	5.07	0.00	0.00	0.51	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	349.91	23.34	9.22	10.59	3.14	0.39	1.18	0.59	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	96.94	5.57	4.90	1.45	1.45	0.33	0.33	0.45	0.45	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	146.35	4.34	7.28	1.40	3.16	0.51	0.74	0.37	0.15	0.07
nasal epithelial cells, donor2	12227-129F4	172.77	6.07	9.38	0.55	5.52	0.00	0.55	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	153.68	23.70	11.27	5.06	3.45	1.61	0.46	0.23	0.00	0.46
neuroblastoma cell line:NB-1	10539-107G8	410.28	36.29	26.00	22.45	28.44	9.54	0.94	5.05	2.25	1.87
neuroblastoma cell line:NBsusSR	10607-108F4	106.92	4.64	5.90	1.27	2.95	0.63	0.63	0.21	0.42	0.42
neuroblastoma cell line:NH-12	10555-107I6	249.90	18.08	8.94	4.85	2.80	0.19	0.56	0.19	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	222.99	14.95	10.20	2.61	1.90	1.42	3.80	0.95	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	151.10	10.14	6.02	2.53	1.90	0.32	2.69	0.32	0.16	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	130.01	10.06	7.45	4.43	1.61	0.60	0.81	0.60	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	231.42	15.89	9.54	5.72	1.27	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	96.35	5.86	2.40	3.46	3.46	0.80	0.00	0.80	0.00	0.53
neutrophil PMN, donor1	12133-128D9	208.25	29.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	239.05	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	265.18	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	452.23	14.04	15.56	1.52	1.35	2.54	0.51	0.34	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	210.53	18.41	22.41	13.61	12.01	5.60	0.80	0.80	1.60	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	103.24	8.66	4.17	2.56	4.17	2.24	0.32	0.64	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	80.67	4.47	3.68	2.36	2.10	0.53	0.79	0.26	0.79	0.00
nucleus accumbens, adult, pool1	10037-101F1	22.50	1.50	3.37	1.87	4.78	0.66	0.09	0.84	0.66	0.75
occipital cortex - adult, donor10196	10172-103C1	22.66	0.00	0.00	2.06	4.12	0.00	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	58.23	1.34	7.78	2.95	12.88	0.27	0.27	1.61	0.27	1.07
occipital cortex, newborn, donor10223	10355-105E4	37.49	2.55	1.82	0.00	4.00	1.46	0.73	0.73	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	28.60	1.84	3.15	3.15	7.61	0.79	1.05	1.05	0.52	0.26
occipital lobe, fetal, donor1	10073-102A1	62.65	6.01	6.01	4.72	6.87	2.57	0.86	1.29	1.29	1.29
occipital pole, adult, pool1	10036-101E9	19.24	1.66	4.42	2.05	6.31	0.71	0.32	0.32	0.47	0.16
olfactory region, adult	10195-103E6	21.78	1.53	1.91	2.87	3.63	0.76	1.15	0.38	0.38	0.00
optic nerve, donor1	10277-104E7	52.03	0.00	6.00	2.00	2.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	231.58	11.39	4.78	2.39	2.85	1.82	0.46	0.57	0.57	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	123.92	8.38	8.93	3.57	3.16	0.69	0.14	0.14	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	292.42	7.45	3.56	3.22	2.71	1.02	1.86	0.17	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	351.49	13.17	13.05	3.23	3.47	0.92	1.04	0.58	0.58	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	129.05	6.47	2.65	4.70	2.06	0.29	0.29	1.76	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	326.08	22.42	6.54	5.61	6.54	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	297.09	15.06	6.36	4.24	2.54	1.70	0.64	1.06	0.85	0.42
ovary, adult, pool1	10020-101D2	62.19	2.71	5.85	1.22	5.15	0.52	0.17	1.05	0.79	0.61
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	160.96	12.10	6.78	3.48	2.20	3.12	1.28	1.10	0.18	0.73
pancreas, adult, donor1	10049-101G4	73.37	0.94	4.70	3.76	5.64	0.00	1.88	1.88	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	192.04	9.78	7.27	0.56	2.24	1.96	1.40	1.40	1.12	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	181.94	11.07	2.38	2.90	1.87	0.34	1.87	0.85	0.68	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	269.24	5.80	4.80	1.82	2.48	0.17	0.33	1.66	0.50	0.33
paracentral gyrus, adult, pool1	10035-101E8	19.31	2.11	3.20	2.29	6.50	0.37	0.55	0.18	0.92	0.09
parietal cortex, adult, donor10258	10373-105G4	20.55	1.47	2.94	0.73	1.47	0.73	1.47	0.73	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	21.63	0.94	2.82	1.88	4.70	0.00	0.00	0.00	1.88	0.94
parietal lobe, adult, donor10252	10157-103A4	29.93	1.71	4.56	1.71	9.12	0.86	1.14	0.86	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	20.80	1.76	4.41	1.50	6.79	0.97	0.35	0.62	0.18	0.18
parietal lobe, fetal, donor1	10072-101I9	69.83	8.73	11.64	5.82	4.85	1.94	0.97	1.94	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	41.50	1.87	0.75	1.12	1.87	1.50	0.00	1.12	0.75	0.75
parotid gland, adult	10199-103F1	39.47	3.08	4.32	1.23	6.17	4.32	0.00	0.62	1.85	0.62
penis, adult	10200-103F2	60.69	2.15	3.76	1.61	5.37	0.00	2.15	0.54	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	154.14	7.62	4.46	0.74	3.16	0.19	1.12	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	221.60	15.44	5.25	5.83	3.93	2.33	1.31	3.79	0.29	0.29
pineal gland - adult, donor10196	10179-103C8	17.42	1.29	2.58	0.65	6.45	0.00	0.00	1.94	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	28.43	2.37	7.70	1.18	6.51	0.59	0.00	0.59	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	17.56	0.63	4.39	1.25	8.15	1.88	0.63	1.88	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	30.35	3.04	6.07	2.02	6.07	0.00	0.00	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	38.57	1.56	6.25	0.52	5.21	0.52	1.04	1.04	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	30.64	1.70	1.70	1.70	10.21	2.55	0.00	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	114.60	3.44	6.88	0.97	1.61	0.32	0.22	0.43	0.32	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	122.76	4.90	4.90	1.85	1.72	2.78	2.38	0.93	0.13	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	162.18	9.65	7.16	4.51	3.27	0.47	0.47	0.62	0.16	0.16
pons, adult, pool1	10033-101E6	16.18	1.03	2.58	0.86	3.61	0.26	0.09	0.26	0.52	0.09
postcentral gyrus, adult, pool1	10032-101E5	25.63	1.83	4.01	2.35	6.02	0.44	0.26	0.52	0.44	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	698.53	60.65	8.37	8.37	2.09	0.00	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	440.64	27.54	11.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	352.07	0.00	23.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	330.65	13.26	15.73	3.35	5.68	1.02	1.89	1.60	0.44	0.29
prostate cancer cell line:PC-3	10439-106E7	369.72	27.04	8.71	7.99	2.72	5.99	1.09	0.91	0.91	1.27
prostate, adult, pool1	10022-101D4	48.43	3.81	3.99	0.63	2.63	1.09	0.09	0.27	0.18	0.09
putamen, adult, donor10196	10176-103C5	25.73	2.12	3.07	2.60	6.85	0.71	1.89	0.24	0.47	0.94
putamen, adult, donor10252	10152-102I8	45.10	0.00	3.92	5.88	7.84	1.96	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	85.24	4.37	3.28	2.19	0.00	3.28	0.00	1.09	0.00	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	13.05	1.69	3.14	2.90	5.32	0.97	0.97	0.24	0.24	0.48
putamen, newborn, donor10223	10365-105F5	53.98	0.00	3.75	0.00	1.50	0.75	0.75	1.50	1.50	1.50
rectal cancer cell line:TT1TKB	10469-106I1	283.95	12.51	7.56	2.04	5.53	2.33	0.29	0.58	0.29	0.00
rectum, fetal, donor1	10067-101I4	125.19	23.65	2.78	9.74	4.17	2.78	0.00	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	213.06	5.94	6.78	4.03	2.54	0.42	0.21	0.00	0.21	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	156.16	3.31	6.63	0.41	7.46	0.83	0.41	0.00	0.00	0.41
retina, adult, pool1	10030-101E3	40.46	1.89	5.07	0.99	5.86	0.40	0.40	0.60	0.10	0.20
retinoblastoma cell line:Y79	10475-106I7	453.35	21.30	18.71	5.98	4.94	2.60	0.78	1.30	0.26	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	204.09	16.60	7.01	9.34	2.34	2.21	0.25	0.98	0.12	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	363.03	30.09	13.78	6.47	2.53	0.56	0.28	0.84	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	112.92	11.37	1.52	2.27	2.27	0.00	0.76	2.27	0.76	0.76
salivary acinar cells, donor1	11771-123I7	134.66	4.37	3.72	0.81	0.97	1.29	2.43	1.29	0.49	0.00
salivary acinar cells, donor2	11772-123I8	127.77	8.54	2.62	1.51	1.93	0.28	1.65	0.41	0.69	0.14
salivary acinar cells, donor3	11773-123I9	180.08	11.25	6.62	2.65	0.00	0.66	0.66	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	29.17	0.57	6.86	0.00	2.86	1.14	0.57	1.14	0.57	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	180.43	9.78	4.81	4.30	3.37	1.01	0.25	1.85	0.67	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	191.02	11.28	5.52	2.23	4.82	0.94	0.59	1.88	0.35	0.24
seminal vesicle, adult	10201-103F3	73.54	4.76	4.76	1.59	3.17	0.00	1.06	1.59	2.12	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	271.10	9.47	7.04	5.59	8.02	1.94	4.86	1.46	1.46	2.19
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	156.26	5.28	5.54	1.01	2.01	2.52	0.25	1.76	1.26	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	269.95	4.01	4.01	4.01	1.00	0.00	3.01	6.02	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	186.17	8.60	3.90	1.21	1.88	1.48	1.48	0.67	0.40	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	144.79	9.06	4.09	6.41	2.43	0.77	0.11	0.33	0.33	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	261.28	11.23	6.97	6.71	3.35	0.77	1.16	0.77	0.90	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	62.42	4.97	8.51	0.71	14.19	0.00	2.84	0.00	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	95.11	3.84	10.31	0.72	8.88	0.12	0.60	0.60	0.72	0.24
skeletal muscle, fetal, donor1	10066-101I3	121.61	5.03	2.01	5.03	4.02	0.00	1.01	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	101.78	13.57	0.00	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	102.26	4.42	3.79	3.16	1.89	0.63	3.16	1.89	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	225.46	35.35	8.34	16.01	7.00	3.00	0.67	1.33	1.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	309.22	18.91	5.99	3.78	2.21	7.88	6.62	1.26	0.32	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	26.79	1.73	12.72	1.35	1.73	0.96	2.89	0.96	0.39	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	261.42	24.56	8.08	18.96	8.08	1.65	0.33	0.49	0.00	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	389.10	11.42	17.21	1.61	4.34	1.29	4.18	2.73	0.00	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	64.07	7.41	5.01	5.23	3.49	2.40	0.00	0.65	0.00	0.44
small intestine, adult, pool1	10024-101D6	268.75	6.57	9.67	3.11	4.90	0.72	0.60	1.07	1.19	0.24
small intestine, fetal, donor1	10064-101I1	159.70	10.32	3.69	3.44	8.60	3.19	3.19	1.47	0.25	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	211.83	8.72	3.59	5.13	4.10	1.03	6.15	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	34.63	1.55	3.88	0.52	2.58	0.26	2.07	0.00	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	83.62	6.16	6.43	5.63	8.58	0.54	0.54	0.27	0.27	0.54
spinal cord - adult, donor10196	10181-103D1	50.70	2.06	3.44	2.75	7.11	0.23	0.46	0.92	0.92	0.00
spinal cord, adult, donor10252	10159-103A6	46.92	1.58	6.31	0.00	10.65	0.39	0.00	0.00	1.58	0.00
spinal cord, adult, donor10258	10369-105F9	24.90	0.69	3.46	2.77	0.00	2.08	1.38	1.38	3.46	0.69
spinal cord, fetal, donor1	10056-101H2	59.76	7.93	4.27	3.05	6.71	0.61	0.61	0.61	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	130.88	1.84	2.30	0.00	2.30	0.46	0.46	3.67	3.67	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	68.85	5.38	3.14	1.64	3.14	1.34	0.00	1.19	0.45	0.75
spleen, adult, pool1	10025-101D7	68.39	1.98	7.27	0.66	1.98	0.33	0.33	0.99	0.22	0.00
spleen, fetal, pool1	10044-101F8	123.79	6.28	6.44	1.83	1.27	0.79	0.48	0.95	0.08	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	131.15	5.18	6.73	3.11	1.97	1.24	0.41	1.35	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	253.67	12.15	8.35	3.04	4.18	1.52	0.38	0.38	0.38	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	121.96	9.78	4.19	3.84	3.49	0.35	2.80	1.40	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	257.23	12.12	4.69	3.91	8.21	0.00	1.56	0.39	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	106.82	4.73	4.05	2.14	5.40	1.69	0.11	1.13	1.01	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	595.58	28.80	6.35	11.01	5.08	0.42	2.54	1.27	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	497.11	34.69	9.73	20.73	4.65	0.85	1.27	1.27	0.85	0.42
stomach, fetal, donor1	10062-101H8	147.38	14.95	6.41	9.61	10.68	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	56.97	1.71	5.70	1.71	3.42	1.14	2.28	1.14	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	60.86	1.87	7.89	1.04	7.89	0.00	1.87	1.04	0.42	0.21
substantia nigra, adult, donor10258	10371-105G2	12.93	1.03	2.07	0.00	1.55	1.03	0.52	2.07	1.03	0.52
substantia nigra, newborn, donor10223	10358-105E7	115.17	4.95	2.12	2.83	5.65	1.41	0.71	1.41	0.71	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	269.85	17.42	12.61	7.57	4.36	6.88	0.92	1.15	0.46	0.46
temporal lobe, adult, pool1	10031-101E4	29.84	2.03	3.22	2.12	6.87	0.85	0.68	0.68	1.10	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	94.73	14.25	8.55	8.55	7.83	2.14	3.56	2.14	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	66.37	7.47	5.71	1.32	3.96	1.76	0.44	3.52	0.88	0.44
tenocyte, donor1	11763-123H8	145.23	5.24	3.49	3.49	1.40	1.05	3.14	1.75	1.75	0.70
tenocyte, donor2	11765-123I1	81.64	4.96	3.43	0.76	1.91	1.53	0.76	1.91	2.67	0.38
tenocyte, donor3	11768-123I4	94.15	4.82	3.34	2.22	1.48	1.48	1.85	2.22	0.37	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	126.62	10.54	7.99	3.74	2.38	1.70	1.87	2.72	0.51	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	710.31	37.30	17.26	13.26	6.32	107.90	9.87	2.16	0.31	4.93
teratocarcinoma cell line:PA-1	10807-111A6	131.11	10.38	5.11	4.18	1.55	2.63	1.39	0.77	0.00	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	75.28	6.47	3.43	3.43	1.65	0.76	0.89	0.38	0.13	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	53.70	3.03	4.16	0.76	0.00	2.65	0.00	0.38	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	34.14	2.73	2.29	0.76	0.98	0.76	0.44	0.55	0.55	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	41.69	3.26	1.30	0.65	0.00	0.98	0.65	0.33	0.00	0.65
testis, adult, pool1	10026-101D8	39.62	1.93	3.01	0.75	4.72	0.75	0.21	0.97	0.00	0.21
testis, adult, pool2	10096-102C6	30.67	1.35	0.90	0.90	4.96	1.80	0.45	1.35	0.00	0.00
thalamus - adult, donor10196	10168-103B6	45.26	5.52	4.42	0.00	7.73	1.10	0.00	1.10	1.10	0.00
thalamus, adult, donor10252	10154-103A1	60.95	2.03	7.19	1.09	5.94	0.16	1.41	0.47	0.78	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	27.71	0.00	1.54	0.00	1.54	0.00	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	21.74	0.82	2.31	0.99	3.95	0.49	0.16	0.66	1.15	0.00
thalamus, newborn, donor10223	10366-105F6	35.09	0.58	0.00	0.58	1.73	2.88	0.00	1.15	1.15	0.00
throat, adult	10209-103G2	96.37	3.00	5.74	1.25	3.25	0.25	2.25	1.00	0.75	0.25
throat, fetal, donor1	10061-101H7	76.18	6.70	4.27	4.88	5.18	4.88	0.61	1.52	0.61	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	295.71	11.13	7.95	9.34	1.79	4.57	1.99	1.39	0.40	1.39
thymus, adult, pool1	10027-101D9	206.68	18.19	10.54	5.87	1.09	4.18	0.80	0.30	0.30	0.10
thymus, fetal, pool1	10043-101F7	157.31	14.65	7.17	3.53	1.25	3.95	0.73	0.52	0.21	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	418.69	16.22	3.99	6.65	1.73	4.39	3.99	0.80	0.13	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	306.48	22.77	9.08	7.54	5.73	1.40	1.40	3.49	1.26	0.14
thyroid, adult, pool1	10028-101E1	92.29	7.65	7.84	3.83	5.88	1.31	0.56	0.65	0.09	0.19
thyroid, fetal, donor1	10060-101H6	66.18	5.01	6.59	4.22	9.49	2.37	1.58	0.26	0.00	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	123.18	3.08	6.16	3.08	3.08	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	145.59	5.12	4.65	1.40	4.65	1.86	1.16	0.23	0.47	0.70
tongue, fetal, donor1	10059-101H5	97.74	3.94	7.09	2.36	13.01	1.58	5.91	0.79	0.39	0.79
tonsil, adult, pool1	10047-101G2	131.13	5.61	8.01	2.50	2.80	2.60	0.70	0.80	0.00	0.10
trachea, adult, pool1	10029-101E2	127.11	5.40	6.54	1.31	3.76	2.29	0.82	7.12	7.44	0.74
trachea, fetal, donor1	10058-101H4	88.10	8.85	4.62	1.92	6.16	3.46	1.54	1.54	1.15	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	109.47	6.02	3.54	4.61	1.06	1.06	0.35	0.35	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	313.98	13.58	6.08	5.67	1.52	1.01	0.51	0.30	0.20	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	758.52	24.29	18.96	7.68	3.13	1.25	2.51	2.35	1.10	0.16
tridermal teratoma cell line:HGRT	10694-109G1	209.28	20.93	0.00	1.90	1.90	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	141.37	9.73	3.47	4.40	5.16	0.59	0.68	1.86	0.42	0.25
umbilical cord, fetal, donor1	10057-101H3	60.51	0.00	4.17	2.09	4.17	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	38.56	1.54	6.14	0.34	2.73	0.51	0.00	1.02	0.00	0.17
uterus, fetal, donor1	10055-101H1	91.64	7.17	3.58	3.07	4.61	2.56	0.00	1.02	0.00	0.00
vagina, adult	10204-103F6	63.97	0.00	5.17	0.65	0.65	0.00	0.65	0.00	0.00	0.65
vein, adult	10191-103E2	63.79	2.19	5.04	0.88	1.53	0.66	0.44	1.53	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	55.54	1.60	2.14	1.87	1.07	0.27	0.80	0.53	0.00	0.80